date,open,high,low,close,volume,title,description,title_sentiment,desc_sentiment,daily_change_pct,market_sentiment,next_day_change_pct,next_day_sentiment
2018-02-28 18:02:40.987,118.0,118.65,115.35,115.85,1262331.0,Granules India rises 2% on EIR from USFDA,This facility was inspected by USFDA in December 2017 and there was 1 observation during the inspection.,neutral,neutral,-1.8220338983050897,negative,-1.8965517241379333,negative
2018-03-01 13:00:21.328,118.0,118.65,115.35,115.85,1262331.0,Granules India arm receives EIR report,"Granules India on Wednesday informed the exchanges that its subsidiary Granules Pharmaceuticals, Inc has received EIR for its unit located at Chantilly, Virginia. The US FDA has issued the Establishme",neutral,neutral,-1.8220338983050897,negative,-1.8965517241379333,negative
2018-03-23 13:03:05.291,103.0,104.0,101.25,103.2,1148774.0,Granules India Limited,"Krishna Prasad Chigurupati has submitted to the Exchange a copy of disclosure under Regulations 10 (6) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011.",neutral,neutral,0.1941747572815561,neutral,2.204801567858893,positive
2018-04-23 18:01:46.311,110.95,113.55,110.0,111.4,3860701.0,Granules India Q4 PAT seen up 3% YoY to Rs. 37.4 cr: KR Choksey,"Net Sales are expected to increase by 21.8 percent Y-o-Y (up 5.4 percent Q-o-Q) to Rs. 432.7 crore, according to KR Choksey.",positive,positive,0.4055881027489886,neutral,-2.328705776981647,negative
2018-05-08 13:00:53.307,100.0,101.8,99.15,101.2,1136112.0,Granules India shares gain 2% on USFDA nod for Methocarbamol tablets,The US Food & Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by company for Methocarbamol tablet 500 mg and 750 mg.,positive,positive,1.2000000000000028,positive,-5.3254437869822535,negative
2018-05-08 18:01:01.762,100.0,101.8,99.15,101.2,1136112.0,Granules India gets USFDA nod for muscle pain tablets,Granules India has received approval from the US health regulator for generic Methocarbamol tablets in two strengths used for the treatment of muscle spasms and pain.The USFDA has approved the abbrevi,neutral,positive,1.2000000000000028,positive,-5.3254437869822535,negative
2018-05-14 10:01:51.849,94.0,96.8,91.2,92.5,1996009.0,Pledged holdings for BSE 500 stocks decline in the March 2018 quarter,"Among the BSE 500 stocks, Centrum Capital, Emami, Granules India and Adani Ports saw the highest increase in pledged promoter holding",negative,positive,-1.5957446808510638,negative,2.116115029842635,positive
2018-05-16 13:01:22.703,97.15,106.7,97.15,103.0,11175725.0,Granules India gets EIR for Telangana facility,Granules India today said that the US health regulator has issued the Establishment Inspection Report (EIR) after completing the audit of its Telangana facility.“The United States Food and Drug Admini,neutral,neutral,6.021616057642814,positive,-7.281553398058252,negative
2018-05-17 10:00:48.489,97.15,106.7,97.15,103.0,11175725.0,Granules India up 7% on USFDA nod for generic Methylergonovine tablets,"The stock rallied 7% to Rs 104 after the company said Granules Pharmaceuticals Inc., a wholly owned subsidiary of the company, received USFDA approval for generic Methylergonovine tablets.",neutral,positive,6.021616057642814,positive,-7.281553398058252,negative
2018-05-17 13:01:52.146,103.0,103.7,93.6,95.5,4636516.0,Granules gets USFDA nod for postpartum haemorrhage prevention drug,"Granules India said its subsidiary has received approval from the US health regulator for Methylergonovine tablets, used for the prevention and control of postpartum haemorrhage",neutral,positive,-7.281553398058252,negative,-6.207259337190943,negative
2018-05-17 23:02:13.665,103.0,103.7,93.6,95.5,4636516.0,Granules India shares climb nearly 7% on USFDA nod for drug,"The scrip advanced by 6.61% to end at Rs103.15 on BSE. Intra-day, it zoomed 10.18% to Rs106.60. On NSE, shares of the company surged 6.67% to close at Rs103.15",positive,positive,-7.281553398058252,negative,-6.207259337190943,negative
2018-05-24 18:02:33.439,81.3,82.0,77.8,79.6,11898625.0,Granules India reports 55% fall in Q4 net profit at Rs 20.4 crore,The company board recommended a final dividend of 25 paise per share of face value of Re 1 each for the financial year 2017-18.,negative,neutral,-2.0910209102091057,negative,-0.1249999999999929,neutral
2018-05-25 10:00:42.359,81.3,82.0,77.8,79.6,11898625.0,Granules India touches 52-week low on 55% dip in Q4 profit,"On Thursday, the company has reported 55 percent fall in its Q4FY18 consolidated net profit at Rs 20.4 crore on the back of weak operational performance.",negative,negative,-2.0910209102091057,negative,-0.1249999999999929,neutral
2018-06-12 13:02:00.940,85.25,88.35,84.8,85.9,8313173.0,Nifty Pharma index up for fifth straight day; Sun Pharma rises 14% on week,"Marksans Pharma, Alembic Pharma, Caplin Point Lab, Ajanta Pharma, Bliss GVS Pharma, Granules India, Aurobindo Pharma and Wockhardt were up in the range of 10% to 30% in past one week.",positive,positive,0.762463343108511,neutral,2.2674418604651194,positive
2018-06-22 13:01:47.541,85.0,85.0,81.65,83.1,5256796.0,"Top intraday trading ideas for afternoon trade for Friday, 22 June 2018",Granules India is a 'Sell' call with a target price of Rs 77 and a stop loss of Rs 86.,neutral,neutral,-2.235294117647065,negative,-0.4229607250755218,neutral
2018-07-23 23:01:43.510,96.25,96.45,88.8,91.1,10847070.0,Granules India Q1 net profit up 41% to Rs 51.7 crore,"The consolidated revenue from the operations of the company stood at Rs 453.23 crore for the quarter under consideration as against Rs 384.73 crore for the same period year ago.

",positive,neutral,-5.350649350649356,negative,1.0857763300760044,positive
2018-08-13 10:00:58.499,102.45,106.8,102.45,106.0,2160799.0,"Top trading ideas by Devang Shah: Buy TCS, PowerGrid and Granules India","Short-term outlook for the market remains positive till Nifty trades above 10,929 levels,says Devang Shah",neutral,positive,3.46510492923377,positive,-1.6532829475673123,negative
2018-08-23 18:00:48.257,115.25,115.45,112.5,113.15,3653468.0,Granules India up 4% on USFDA approval for Ranitidine tablets,The company is intend to commercialise this product shortly.,positive,neutral,-1.822125813449019,negative,0.5701754385964962,neutral
2018-09-06 18:00:10.910,121.5,122.4,118.8,121.2,6479442.0,"Sun Pharma, Glenmark Pharma, Hikal hit 52-week highs; Aurobindo surges 8%","Granules India, Hikal, Pfizer, Lincoln Pharmaceuticals, Astrazeneca Pharma India and Aarti Drugs were up between 4% and 7%.",positive,positive,-0.2469135802469112,neutral,-0.7083333333333286,neutral
2018-10-17 23:01:30.682,98.45,99.35,93.5,94.2,4404528.0,Granules India Q2 PAT seen up 4.4% YoY to Rs. 40 cr: HDFC Securities,"Net Sales are expected to increase by 18.5 percent Y-o-Y (up 2.6 percent Q-o-Q) to Rs. 470 crore, according to HDFC Securities.",positive,positive,-4.316912138141189,negative,-0.107758620689649,neutral
2018-10-29 10:00:57.037,92.0,100.5,91.35,100.0,8751228.0,Granules India gains 5% as USFDA completes inspection at US facility,"Granules Pharmaceuticals, Inc. will respond to the observations within this week.",positive,neutral,8.695652173913043,positive,-3.316831683168312,negative
2018-10-29 18:00:54.882,101.0,103.5,95.75,97.65,12461704.0,Granules India arm gets 2 observations from USFDA,"Granules India&rsquo;s US subsidiary has received two observations from the US health regulator following the completion of inspection.&ldquo;Granules Pharmaceuticals Inc, a wholly-owned foreign subsi",neutral,neutral,-3.316831683168312,negative,0.5632360471070119,neutral
2018-10-30 10:01:44.596,101.0,103.5,95.75,97.65,12461704.0,"'BUY' or 'SELL' ideas from experts for Tuesday, 30 October 2018",Granules India is a 'Buy' call with a target price of Rs 110 and a stop loss of Rs 94.,neutral,neutral,-3.316831683168312,negative,0.5632360471070119,neutral
2018-11-27 13:01:43.383,88.4,88.5,84.3,86.0,7086716.0,Granules India arm gets USFDA nod for narcolepsy treatment drug,Granules India’s subsidiary has received approval from the US health regulator for Methylphenidate Hydrochloride extended-release tablets used in the treatment of a sleep disorder called narcolepsy.Th,neutral,positive,-2.714932126696839,negative,3.428239395700178,positive
2019-01-29 18:00:27.671,94.3,96.0,90.7,91.85,4414510.0,"Granules India Standalone December 2018 Net Sales at Rs 581.15 crore, up 40.84% Y-o-Y","Granules India Standalone December 2018 Net Sales at Rs 581.15 crore, up 40.84% Y-o-Y",positive,positive,-2.5980911983032904,negative,-1.831896551724141,negative
2019-01-29 18:02:22.905,94.3,96.0,90.7,91.85,4414510.0,"Granules India Consolidated December 2018 Net Sales at Rs 631.78 crore, up 53.82% Y-o-Y","Granules India Consolidated December 2018 Net Sales at Rs 631.78 crore, up 53.82% Y-o-Y",positive,positive,-2.5980911983032904,negative,-1.831896551724141,negative
2019-01-30 13:00:31.805,92.8,93.85,90.3,91.1,1296204.0,"Granules India gains 8% on robust Q3 show, interim dividend announcement",Revenue of the company rose 53.8 percent to Rs 631.8 crore versus Rs 410.7 crore.,positive,positive,-1.831896551724141,negative,-2.7442371020856204,negative
2019-03-08 13:00:06.859,104.55,114.4,101.75,111.0,12323986.0,Granules India surges 7% post co promoters sell shares worth Rs 50cr,"The promoters are also monetizing personal assets worth up to another Rs 550 crore, which is expected to be complete shortly.",positive,positive,6.16929698708752,positive,3.1081081081081106,positive
2019-03-08 18:00:38.657,104.55,114.4,101.75,111.0,12323986.0,"Granules India’s promoters offload equity, assets worth ₹100 cr; scrip surges over 6.50%",Granules India Ltd promoters off loaded 50 lakh shares for ₹ 50.54 crore to a group of investors in a block deal on the stock exchanges. In a release issued here on Friday. Hyderabad-based tablet-make,positive,neutral,6.16929698708752,positive,3.1081081081081106,positive
2019-04-18 13:01:53.201,116.0,116.4,112.1,113.65,758239.0,Granules India gets USFDA nod for pain relief drug,"Drug firm Granules India on Thursday said it has received approval from the US health regulator for Acetaminophen tablets, used for temporary pain relief. The approved product is bio-equivalent to the",neutral,positive,-2.0258620689655125,negative,2.237823606845105,positive
2019-04-18 18:02:04.412,116.0,116.4,112.1,113.65,758239.0,Granules India gets USFDA nod for pain relief drug,"The approved product is bioequivalent to the reference listed drug product (RLD), Tylenol tablets, extended release.",neutral,neutral,-2.0258620689655125,negative,2.237823606845105,positive
2019-05-09 18:01:05.056,113.9,115.1,108.55,110.2,1935186.0,"Granules India Consolidated March 2019 Net Sales at Rs 613.32 crore, up 21.73% Y-o-Y","Granules India Consolidated March 2019 Net Sales at Rs 613.32 crore, up 21.73% Y-o-Y",positive,positive,-3.248463564530292,negative,0.2724795640327079,neutral
2019-05-09 18:01:05.246,113.9,115.1,108.55,110.2,1935186.0,"Granules India Standalone March 2019 Net Sales at Rs 561.00 crore, up 18.52% Y-o-Y","Granules India Standalone March 2019 Net Sales at Rs 561.00 crore, up 18.52% Y-o-Y",positive,positive,-3.248463564530292,negative,0.2724795640327079,neutral
2019-05-09 23:02:22.598,113.9,115.1,108.55,110.2,1935186.0,Granules India Q4 profit zooms over 3-fold to Rs 64 cr,"Drug firm Granules India on Thursday reported over three-fold jump in consolidated net profit to Rs 64.03 crore for the March quarter of 2018-19, mainly on account of robust sales. The company posted",positive,positive,-3.248463564530292,negative,0.2724795640327079,neutral
2019-05-27 13:00:30.345,112.4,115.25,112.4,115.0,808352.0,Granules gets USFDA nod for ADHD treatment drug,"Drug firm Granules India on Monday said its subsidiary has received approval from the US health regulator for Methylphenidate Hydrochloride extended-release capsules, used for the treatment of attenti",neutral,positive,2.313167259786472,positive,-0.8771929824561403,neutral
2019-06-19 18:02:13.637,93.4,95.0,91.4,94.0,583042.0,Granules India jumps 9% after chairman expects pledge shares to go down further,"Krishna Prasad Chigurupati, Chairman & MD, Granules India told CNBC-TV18 that currently, promoter pledge is at 43 percent and in the next few weeks, it is going to go down",positive,neutral,0.6423982869378954,neutral,-0.53475935828877,neutral
2019-07-30 18:01:50.503,90.75,92.9,89.6,91.0,902924.0,Granules India Q1 net up 61% at Rs 83 cr,"Granules India Ltd’s consolidated net profit increased 61 per cent at Rs 83 crore in the first quarter ended June 30, 2019, compared to Rs 52 crore in the corresponding quarter of the previous year. T",positive,positive,0.2754820936639118,neutral,-0.0545553737043222,neutral
2019-08-06 18:02:07.682,93.2,94.9,92.5,93.65,631688.0,Granules India’s arm gets USFDA approval for Amphetamine Sulfate tablets,Drug firm Granules India on Tuesday said its US arm has received approval from the USFDA for a generic central nervous system stimulant drug- Amphetamine Sulfate tablets. The US Food &amp;amp; Drug Ad,positive,positive,0.4828326180257541,neutral,3.3653846153846216,positive
2019-08-09 10:00:34.681,98.5,99.6,95.8,96.15,483976.0,Granules India (₹97.3): Buy,"The stock of Granules India has gained 4 per cent with good volume on Thursday, breaking above an immediate resistance at ₹93. This rally provides traders with a short-term view an opportunity to buy",neutral,positive,-2.385786802030452,negative,-2.157894736842102,negative
2019-09-12 18:01:53.482,104.15,104.4,100.5,102.3,413635.0,Granules India jumps 6% on Establishment Inspection Report from USFDA for Bonthapally unit,Bonthapally facility is one of the world's largest single site Paracetamol API manufacturing plant by volume.,positive,neutral,-1.7762842054728838,negative,1.6176470588235352,positive
2019-09-16 13:00:10.544,104.1,106.45,102.2,104.0,817355.0,Granules India enters into agreement with Ajinomoto OmniChem; stock trades flat,"The company has entered into an agreement with SA. Ajinomoto OmniChem N.V., JV for sale of 4.28cr equity shares held by the company in Granules OmniChem for consideration of Rs109.85cr.",positive,positive,-0.0960614793467764,neutral,1.377018043684713,positive
2019-09-16 18:02:25.450,104.1,106.45,102.2,104.0,817355.0,Granules India gains on stake sale in JV to Ajinomoto OmniChem,Conclusion of this transaction is subject to fulfillment of certain closing conditions as well as customary government approvals.,positive,neutral,-0.0960614793467764,neutral,1.377018043684713,positive
2019-09-16 23:01:35.779,104.1,106.45,102.2,104.0,817355.0,Granules India enters into agreement with Ajinomoto OmniChem,"Granules India has entered into an agreement with SA Ajinomoto OmniChem NV, the joint venture partner, for sale of about 4.29 crore shares held by the company in Granules OmniChem Private Limited for",positive,positive,-0.0960614793467764,neutral,1.377018043684713,positive
2019-10-14 18:01:41.530,100.9,100.95,96.15,96.75,316759.0,Granules India to exit from China joint venture,"Hyderabad (Telangana) [India], Oct 14 (ANI): Granules India Ltd said on Monday it will divest its entire equity shareholding in its Chinese joint venture Granules Biocause Pharmaceuticals.",neutral,neutral,-4.112983151635287,negative,0.0516528925619805,neutral
2019-10-21 13:02:33.350,102.9,119.85,102.55,114.35,8716425.0,Granules India gets USFDA nod for allergy treatment drug,"Granules India said it has received approval for Fexofenadine Hydrochloride tablets. The approved product is bio-equivalent to the reference listed drug product (RLD), Allegra Allergy Tablets, 60 mg and 180 mg, of Sanofi-Aventis US LLC. 
",neutral,positive,11.127308066083565,positive,0.0,neutral
2019-10-22 18:01:24.410,116.0,118.8,113.2,116.0,2382762.0,"Granules India trades near 52-wk high, surges 18% after PAT jumps 59% in Q2","While operational income grew 20 per cent at Rs 700 crore as against Rs 581 crore in the year ago quarter, Ebitda (earnings before interest, tax, depreciation and amortization) margin expanded 322 bps",positive,positive,0.0,neutral,6.4419795221842975,positive
2019-10-23 23:00:22.075,117.2,125.8,117.0,124.75,5803624.0,Granules India’s Q2 net doubles at Rs 96 cr,"Granules India Limited’s consolidated net profit doubled at ₹96 crore, excluding joint venture profit, in the second quarter ended September 30, against ₹47 crore in the corresponding quarter of the",positive,positive,6.4419795221842975,positive,-0.9596161535385868,negative
2019-11-28 13:02:37.237,129.2,132.1,126.0,127.25,1775984.0,Granules India hits fresh 52-wk high on reports of PE firms eyeing stake,"The Blackstone Group, KKR & Co, Apax Partners, Advent International and Bain Capital are among the leading global PE companies in early-stage discussions to acquire Granules India, as per reports",neutral,neutral,-1.509287925696586,negative,-4.168289832489283,negative
2019-12-13 23:02:50.031,129.9,133.0,128.55,130.75,1657157.0,Granules to sell full stake in China JV,"Granules India is selling its entire stake in Granules-Biocause Pharmaceutical Co., an equal joint venture in China, to JV partner Hubei Biocause Heilen Pharmaceutical Co for RMB 109 million.On Friday",neutral,neutral,0.6543494996150842,neutral,-1.248108925869877,negative
2019-12-16 10:00:26.506,132.2,133.4,129.9,130.55,1323503.0,"Top stocks in focus: Sun Pharma, RIL, Granules India, Adani Transmission",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-1.248108925869877,negative,-3.6287242169595104,negative
2019-12-16 13:01:07.905,130.9,131.0,125.3,126.15,1025230.0,Granules India share price rises 1% on stake sale in Chinese JV,The conclusion of the transaction is subject to the fulfillment of certain closing conditions and regulatory approvals.,positive,neutral,-3.6287242169595104,negative,0.8270972823946412,neutral
2019-12-24 13:01:53.853,126.9,129.3,126.0,126.1,562174.0,Granules India gets USFDA nod for allergy treatment drug,Granules India on Tuesday said the US health regulator had given its approval to the abbreviated new drug application filed by the drug firm for Loratadine tablets used to treat allergies. “The US Foo,neutral,positive,-0.6304176516942563,neutral,-3.0291109362706488,negative
2019-12-24 13:02:18.156,126.9,129.3,126.0,126.1,562174.0,"Granules India receives ANDA approval for Loratadine Tablets USP, 10 mg",Granules India Ltd. intends to commercialize this product shortly.,positive,neutral,-0.6304176516942563,neutral,-3.0291109362706488,negative
2019-12-27 18:00:37.990,124.0,125.2,122.9,123.55,464405.0,Karvy CMD Parthasarathy resigns as Independent Director of Granules India Board,"C Parthasarathy, Chairman and Managing Director of the Hyderabad-based Karvy Group, has resigned as an Independent Director on Board of pharmaceuticals company Granules India Limited, which he was ser",neutral,neutral,-0.3629032258064539,neutral,0.6446414182111292,neutral
2020-01-07 13:01:39.864,122.85,132.15,121.6,130.0,1964685.0,"Granules India, Glenmark Pharma rally 3% on drug approvals from USFDA","Granules India got the nod for a painkiller, while Glenmark got it for Deferasirox tablets used in the treatment for chronic iron overload syndrome.",positive,neutral,5.820105820105825,positive,-0.3773584905660377,neutral
2020-01-12 13:01:25.153,129.0,132.55,126.6,131.15,892501.0,Granules India recalls over 2.3 cr ranitidine tablets from US,"Drug firm Granules India is recalling over 2.3 crore ranitidine tablets, used to treat ulcers of the stomach and intestines, from the US market, the latest report of the American health regulator said",negative,negative,1.6666666666666712,positive,0.0381679389313063,neutral
2020-01-13 13:00:48.828,131.0,133.05,130.0,131.05,561394.0,Granules India says ‘voluntarily’ recalling Ranitidine tabs,Drug firm Granules India on Monday said it is ‘voluntarily’ recalling Ranitidine tablets used to treat ulcers of the stomach and intestines. “Ranitidine is being recalled by various producers from the,negative,negative,0.0381679389313063,neutral,4.441913439635553,positive
2020-01-13 13:02:37.971,131.0,133.05,130.0,131.05,561394.0,Granules India clarifies on news item for re-call of Ranitidine; stock up 1%,"The quantities being referred in various news websites at this point of time is the last 1-year sale from Granules India Limited to Granules USA, Subsidiary of the company, the company said in the filing.",positive,neutral,0.0381679389313063,neutral,4.441913439635553,positive
2020-01-13 13:03:25.807,131.0,133.05,130.0,131.05,561394.0,Granules India says 'voluntarily' recalling ranitidine tabs,"""Ranitidine is being recalled by various producers from the US market as they contain unacceptable levels of N — nitrosodimethylamine (NDMA). Granules India Ltd is recalling this product voluntarily,"" the drug firm said in a filing to BSE.",negative,negative,0.0381679389313063,neutral,4.441913439635553,positive
2020-01-13 13:06:44.147,131.0,133.05,130.0,131.05,561394.0,Granules India says 'voluntarily' recalling ranitidine tabs,Granules India has said that it has received multiple queries on the news item for recall of ranitidine by the drug firm. The company is in the process of recall from channel partners and the exact quantities are being estimated.,negative,negative,0.0381679389313063,neutral,4.441913439635553,positive
2020-01-16 18:00:46.675,146.0,146.25,139.55,141.75,2034117.0,Granules India to consider the proposal of buyback of equity shares,"The company to consider buyback of equity shares of the company on January 21, 2020.",neutral,neutral,-2.910958904109589,negative,3.011204481792705,positive
2020-01-21 10:03:20.319,147.7,152.85,138.1,140.65,10072766.0,"Board Meetings Today: HDFC AMC, ZEEL, Havells India, IndiaMart and Granules India",It makes sense to have a look at the corporate agendas for the days as announced to the stock exchanges.,neutral,neutral,-4.773188896411634,negative,5.494892567805574,positive
2020-01-21 10:05:31.691,147.7,152.85,138.1,140.65,10072766.0,"Granules India: Results, buyback meet eyed", The board of Granules India will meet on Tuesday to consider quarterly results for the period ended December 2019. The Hyderabad-based firm’s board will also consider a proposal for buyback of equity,neutral,neutral,-4.773188896411634,negative,5.494892567805574,positive
2020-01-21 18:01:18.249,141.95,149.9,141.8,149.75,4748511.0,Granules India reports 10% yoy rise in PAT for Q3; stock slips 4.5%,Its income from operations rose 11% yoy to Rs704cr in Q3FY20.,positive,positive,5.494892567805574,positive,6.635545181727254,positive
2020-01-21 23:02:28.730,141.95,149.9,141.8,149.75,4748511.0,Granules India reports 10 pc rise in PAT for Q3,"Hyderabad (Telangana) [India], Jan 21 (ANI): Granules India Ltd said on Tuesday reported a net profit of Rs 64 crore in the quarter ending December (Q3 FY20), rising over 10.3 per cent from Rs 58 crore in Q3 FY19.",positive,positive,5.494892567805574,positive,6.635545181727254,positive
2020-01-22 13:05:04.085,149.95,161.1,149.1,159.9,6134627.0,Granules India's Q3 profit rises 6%: Highlights from the company's conference call,"Operating numbers were very strong as earnings before interest, tax, depreciation and amortisation (EBITDA) surged 44 percent YoY to Rs 163.15 crore and margin expanded to 23.17 percent (from 17.93 percent) in Q3.",positive,positive,6.635545181727254,positive,-2.8301886792452837,negative
2020-01-23 13:01:35.458,159.0,159.0,154.0,154.5,1710506.0,Granules India hit fresh 52-week high; brokerages positive on growth prospects,Domestic brokerage firm Sharekhan by BNP Paribas has maintained a positive view on the stock with an upside potential of 12-15 percent.,positive,positive,-2.8301886792452837,negative,-0.6535947712418301,neutral
2020-02-04 13:00:20.131,147.5,154.6,146.9,154.15,1880744.0,Granules India divests entire stake in JV Biocause Pharmaceutical,"The pharma company has completed the divestment of its entire stake in Granules-Biocause Pharmaceutical Co., an overseas joint venture company in China for consideration of RMB 109 million.",neutral,neutral,4.50847457627119,positive,4.761904761904758,positive
2020-02-04 13:00:52.304,147.5,154.6,146.9,154.15,1880744.0,Granules India divests entire stake in Granules-Biocause Pharmaceutical,"Granules India Ltd on Tuesday said it has divested its entire stake in Granules-Biocause Pharmaceutical Co Limited, a joint venture company located in China. Last year, Granules India had intimated ab",neutral,neutral,4.50847457627119,positive,4.761904761904758,positive
2020-02-04 13:02:06.624,147.5,154.6,146.9,154.15,1880744.0,Granules India divests entire stake in JV Biocause Pharmaceutical,Shares of Granules India Ltd were trading at Rs 146 a piece on BSE,neutral,neutral,4.50847457627119,positive,4.761904761904758,positive
2020-02-04 13:04:52.138,147.5,154.6,146.9,154.15,1880744.0,Granules India divests entire stake in Granules-Biocause Pharmaceutical,"Last year, Granules India had intimated about the divestment of the entire stake of the JV company for a total consideration of RMB 109 million (around Rs 110.8 crore).",neutral,neutral,4.50847457627119,positive,4.761904761904758,positive
2020-02-05 13:02:03.652,154.35,162.5,153.1,161.7,2767079.0,Granules India gets USFDA nod for Valganciclovir hydrochloride oral solution,"Drug firm Granules India Ltd on Wednesday said its foreign arm has received approval from the US health regulator for Valganciclovir hydrochloride oral solution, an antiviral medication.“The US Food &",neutral,positive,4.761904761904758,positive,0.8039579468150968,neutral
2020-02-05 13:03:51.053,154.35,162.5,153.1,161.7,2767079.0,Granules India arm gets USFDA nod for Valganciclovir hydrochloride oral solution,"""The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc, a-wholly owned foreign subsidiary of Granules India Ltd for Valganciclovir hydrochloride for oral solution, 50 mg/ml,"" the company said in a regulatory filing.",neutral,positive,4.761904761904758,positive,0.8039579468150968,neutral
2020-02-05 13:04:08.287,154.35,162.5,153.1,161.7,2767079.0,Granules India arm gets USFDA nod for generic version of Roche antiviral,Valganciclovir hydrochloride solution is an antiviral medication used to treat cytomegalovirus infections.,neutral,neutral,4.761904761904758,positive,0.8039579468150968,neutral
2020-02-05 13:04:36.054,154.35,162.5,153.1,161.7,2767079.0,Granules India share price jumps 5% on USFDA nod for antiviral medicine,Domestic brokerage firm Sharekhan by BNP Paribas has maintained a positive view on the stock with an upside potential of 12-15 percent while Anand Rathi Share has a buy recommendation with a target price of Rs 181.,positive,positive,4.761904761904758,positive,0.8039579468150968,neutral
2020-02-06 13:02:27.595,161.7,167.3,160.75,163.0,2320193.0,Granules Pharmaceuticals gets USFDA nod for Colchicine tablets,"Granules India on Thursday said its wholly owned foreign arm has received US health regulator’s approval for Colchicine tablets, used in the treatment of familial mediterranean fever. Familial mediter",neutral,positive,0.8039579468150968,neutral,2.839506172839503,positive
2020-02-06 13:05:13.480,161.7,167.3,160.75,163.0,2320193.0,Granules India hits 52-week high after USFDA approval,Colchicine tablets are used in the treatment of Familial Mediterranean Fever.,positive,neutral,0.8039579468150968,neutral,2.839506172839503,positive
2020-02-11 18:01:25.438,163.1,163.85,158.05,160.0,1149583.0,Granules India gets tentative nod from USFDA for generic Colchicine capsules,"The US Food and Drug Administration (USFDA) has tentatively approved the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals Inc for Colchicine capsules in the strength of 0.6 mg, Granules India said in a filing to the BSE.",neutral,positive,-1.9006744328632708,negative,6.218749999999993,positive
2020-02-11 18:03:23.494,163.1,163.85,158.05,160.0,1149583.0,Granules India gets tentative USFDA nod for Colchicine capsules for gout,"The USFDA has tentatively approved the abbreviated new drug application filed by Granules Pharmaceuticals for Colchicine capsules in the strength of 0.6 mg, Granules India said in a filing to BSE.",positive,positive,-1.9006744328632708,negative,6.218749999999993,positive
2020-02-11 18:03:55.972,163.1,163.85,158.05,160.0,1149583.0,Granules India gets tentative approval of Colchicine capsules,"The Mitigare brand and generic had U.S. sales of approximately $84 million MAT for the most recent twelve months ending in December 2019, according to IQVIA Health.",positive,neutral,-1.9006744328632708,negative,6.218749999999993,positive
2020-02-12 10:01:10.976,163.1,163.85,158.05,160.0,1149583.0,Granules gets nod from USFDA for generic Colchicine capsules,Drug firm Granules India has received tentative approval from the US health regulator for its generic Colchicine capsules indicated for prevention of gout flares in adults. The US Food and Drug Admin,neutral,positive,-1.9006744328632708,negative,6.218749999999993,positive
2020-02-13 13:00:39.274,170.9,179.5,168.1,176.75,5262449.0,Granules India gets tentative approval from USFDA; stock gains 2%,Granules now has a total of 23 ANDA approvals from USFDA (21 Final approvals and 2 tentative approvals).,positive,neutral,3.4230544177881765,positive,-0.9428571428571462,negative
2020-02-13 13:02:59.745,170.9,179.5,168.1,176.75,5262449.0,Granules India gets tentative nod from USFDA for expectorant tablets,"""US Food & Drug Administration (USFDA) has tentatively approved its Abbreviated New Drug Application for Guaifenesin extended-release tablets, 600 mg and 1200 mg (OTC),"" the company said in a filing to the BSE.",neutral,positive,3.4230544177881765,positive,-0.9428571428571462,negative
2020-02-20 13:01:32.867,187.65,188.45,182.0,184.3,1205705.0,API makers surge up to 110% in 50 days as virus hits Chinese exports,Brokerage sees coronavirus crisis as a positive for companies like Granules India and Natco.,positive,positive,-1.7852384758859547,negative,-4.777594728171328,negative
2020-03-05 18:01:24.402,167.0,176.9,165.05,171.1,2385485.0,Granules India share price gains 4% on USFDA nod,The company now have a total of 24 ANDA approvals from US FDA (22 Final approvals and 2 tentative approvals).,positive,neutral,2.455089820359278,positive,-3.1136638452237038,negative
2020-03-10 23:01:20.273,162.8,173.9,162.8,171.0,2402270.0,Granules’ buyback gets approval,"Shareholders of Granules India have approved a buyback proposal. Earlier, the company’s board had approved the buyback worth ₹250 crore. It had cleared a proposal to buyback up to 1.25 crore shares fo",neutral,positive,5.036855036855029,positive,-5.454545454545454,negative
2020-03-11 13:03:34.783,165.0,165.75,141.1,156.0,3327042.0,Granules India share price gains 7% on buyback approval,"The buyback committee has approved March 20, 2020 as the record date.",positive,neutral,-5.454545454545454,negative,10.422535211267617,positive
2020-03-11 18:03:03.898,165.0,165.75,141.1,156.0,3327042.0,Granules India soars 6% on buyback approval,The company's shareholders approved buyback worth Rs250cr.,positive,neutral,-5.454545454545454,negative,10.422535211267617,positive
2020-03-18 13:00:20.009,128.0,143.25,126.05,129.5,1924574.0,Granules to turn ex-date for buyback tomorrow, Shares of Granules India will turn ex-date on Thursday for the proposed ₹250-crore buyback. The Hyderabad-based company plans to buy back up to 1.25 crore shares at ₹200 apiece. As the buyback is pro,neutral,neutral,1.171875,positive,4.566037735849065,positive
2020-04-07 18:02:40.214,155.0,175.0,154.1,172.7,3794614.0,Granules India's Visakhapatnam unit gets EU GMP approval; stock zooms 10%,"This approval is valid for three years, Granules said in the filing.",neutral,neutral,11.41935483870967,positive,-3.9499857914180105,negative
2020-04-07 18:04:09.313,155.0,175.0,154.1,172.7,3794614.0,Granules India share price gains 12% on EU GMP approval,The EU nod for the company's Visakhapatnam facility will be valid for three years. ,positive,neutral,11.41935483870967,positive,-3.9499857914180105,negative
2020-04-09 13:00:27.213,175.95,180.0,166.65,169.0,3087769.0,"Granules India gets approval of Butalbital, Acetaminophen and Caffeine Capsules; stock up ~2%","Butalbital, Acetaminophen and Caffeine Capsules are used for the relief of the symptom complex of tension (or muscle contraction) headache.",positive,neutral,-3.9499857914180105,negative,0.3783469150174489,neutral
2020-04-09 23:03:01.761,175.95,180.0,166.65,169.0,3087769.0,USFDA nod for Granules product,Granules India on Thursday said the U.S. Food and Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by the company’s wholly owned subsidiary Granules Pharmaceu,neutral,positive,-3.9499857914180105,negative,0.3783469150174489,neutral
2020-04-24 04:29:00.000,160.0,169.9,159.2,167.3,5446088.0,Granules India gets approval for Trospium Chloride ER Capsules; stock rises over 3.5%,"Trospium Chloride Extended-Release Capsules are a muscarinic antagonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency, Granules India said.",positive,neutral,4.562500000000007,positive,-0.6620610247553121,neutral
2020-04-24 05:30:00.000,160.0,169.9,159.2,167.3,5446088.0,BRIEF-Granules India Gets U.S. FDA Approval Of Trospium Chloride ER Capsules - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,4.562500000000007,positive,-0.6620610247553121,neutral
2020-04-24 10:05:00.000,160.0,169.9,159.2,167.3,5446088.0,Granules India share price rises 6% on USFDA nod,Granules now has a total of 26 ANDA approvals from US FDA (24 Final approvals and 2 tentative approvals).,positive,neutral,4.562500000000007,positive,-0.6620610247553121,neutral
2020-04-24 13:27:00.000,160.0,169.9,159.2,167.3,5446088.0,Granules India gets USFDA nod for overactive bladder treatment capsule,"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc, a wholly owned foreign subsidiary of Granules India Ltd, for Trospium Chloride extended-release capsules, 60 mg, the company said in a regulatory filing.",neutral,positive,4.562500000000007,positive,-0.6620610247553121,neutral
2020-04-24 18:16:00.000,160.0,169.9,159.2,167.3,5446088.0,Granules India share price rises over 5% on USFDA nod to Trospium Chloride capsules,Granules India share price closed higher today after the firm received approval of a drug from the US drug regulator for treatment of overactive bladder. Share price of Granules India rose up to 5.83% to Rs 169.85 compared to the previous close of Rs 160.,positive,positive,4.562500000000007,positive,-0.6620610247553121,neutral
2020-04-27 03:08:00.000,173.7,175.4,171.05,172.55,3025748.0,Granules India gets USFDA approval of Vigabatrin for Oral Solution,"Vigabatrin for Oral Solution (brand and generic) products had the US sales of ~$255 million MAT for the most recent twelve months ending in February 2020, according to IQVIA Health.",positive,neutral,-0.6620610247553121,neutral,-2.400685910260068,negative
2020-04-27 05:30:00.000,173.7,175.4,171.05,172.55,3025748.0,BRIEF-Granules India Gets Approval For Vigabatrin - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.6620610247553121,neutral,-2.400685910260068,negative
2020-04-28 07:26:00.000,174.95,176.1,170.35,170.75,1568532.0,"Hot Stocks | Granules India, Dr Lal Path Lab, Navin Flourine are short-term buys","Positional Support for Nifty is seen at 8,900, and unless that is breached, the short-term trend of the market would be considered bullish only.",neutral,positive,-2.400685910260068,negative,-1.83352735739232,negative
2020-05-20 20:11:14.000,172.6,173.6,167.6,168.5,1291854.0,Granules India (₹171.7): Buy,"Accompanied by above average volume, the stock of Granules India jumped 4 per cent on Wednesday. During the rally, it decisively broke a key resistance at ₹167 and exceeded the 21-DMA.The stock has be",neutral,positive,-2.3754345307068334,negative,-1.1904761904761905,negative
2020-05-25 11:23:00.000,168.0,170.6,166.0,168.3,905920.0,Slideshow | Reliance Securities bets on these 5 stocks for 11-68% returns,"Reliance Securities bet on Bharti Airtel, Granules India, Aurobindo Pharma, Escorts and Alembic Pharma with an upside of 11-68 percent.",neutral,positive,0.1785714285714353,neutral,3.2267613972764884,positive
2020-05-28 05:30:00.000,175.2,179.9,170.2,171.7,2850643.0,BRIEF-Granules India Says FDA Did Not Detect NDMA In Product Samples - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.997716894977169,negative,-2.2753128555176336,negative
2020-05-28 12:27:00.000,175.8,177.8,169.8,171.8,2890447.0,Granules India stock advances after USFDA finds no NDMA impurities,The company has clarified and said that it has received communication from the USFDA stating that the USFDA has tested samples from a few lots of the Company’s API and Finished dosage tablets and the results “did not detect NDMA.”,neutral,neutral,-2.2753128555176336,negative,-0.4335260115606936,neutral
2020-06-01 05:30:00.000,173.0,176.2,170.5,172.25,2199175.0,BRIEF-Granules India To Buyback Shares For Up To 2.5 Bln Rupees - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.4335260115606936,neutral,4.644495412844033,positive
2020-06-01 09:55:00.000,173.0,176.2,170.5,172.25,2199175.0,Granules India to offer buyback on June 08; plans to raise Rs250cr,Granules has set a price band of Rs200 per equity share for this buyback.,positive,neutral,-0.4335260115606936,neutral,4.644495412844033,positive
2020-06-02 05:30:00.000,174.4,182.85,172.5,182.5,4965548.0,BRIEF-Granules India March-Qtr Consol Profit Rises - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,4.644495412844033,positive,-1.6397849462365652,negative
2020-06-02 09:01:09.000,174.4,182.85,172.5,182.5,4965548.0,"Stocks in focus: RIL, Kotak Mahindra Bank, Britannia Industries, IndiGo, IGL stocks to remain in news","Motherson Sumi Systems, Dhampur Sugar Mills, Dolat Investments, Britannia Industries, IndiGo, Granules India, Tata Teleservices and Zydus Wellness are among 18 companies which are scheduled to announce their March quarter earnings today",neutral,neutral,4.644495412844033,positive,-1.6397849462365652,negative
2020-06-03 07:50:42.000,186.0,188.5,179.5,182.95,4884550.0,"In Pics | Stocks In The News: Britannia, InterGlobe Aviation, Kotak Bank, Just Dial",Lupin | ADF Foods | Coromandel International | Quess Corp | Minda Industries | Syngene International | Tribhovandas Bhimji Zaveri | Granules India | Everest Organics | Transport Corporation of India | Axita Cotton are also in focus today.,neutral,neutral,-1.6397849462365652,negative,0.3006285870456471,neutral
2020-06-03 09:50:55.000,186.0,188.5,179.5,182.95,4884550.0,"Granules India Standalone March 2020 Net Sales At Rs 486.87 Crore, Down 13.21% Y-o-Y",,neutral,neutral,-1.6397849462365652,negative,0.3006285870456471,neutral
2020-06-03 18:24:00.000,182.95,189.0,181.25,183.5,3303276.0,Granules India sees 44% rise in Q4 PAT to Rs92.3cr; stock up 2%,Granules India logged rise of 44% yoy in its net profit to Rs92.3cr in Q4FY20 compared to Rs64cr in Q4FY19.,positive,positive,0.3006285870456471,neutral,-1.0486689970422096,negative
2020-06-04 14:39:00.000,185.95,187.8,183.0,184.0,1356362.0,"Stock Ideas: Anand Rathi has a buy call on Granules India, target price Rs 227",. The brokerage expects ~25 per cent/~23 per cent revenue/PAT CAGRs over FY20-22.,positive,neutral,-1.0486689970422096,negative,-2.0161290322580645,negative
2020-06-05 09:34:45.000,185.95,187.8,183.0,184.0,1356362.0,Buy Granules India; Target Of Rs 227: Anand Rathi,"Anand Rathi is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 227 in its research report dated June 03, 2020.",neutral,positive,-1.0486689970422096,negative,-2.0161290322580645,negative
2020-06-10 08:13:00.000,181.85,206.9,181.75,202.3,14288780.0,Over 10% gain! Granules India shines on 3rd day of Rs200cr buyback offer,"The company will settle bids on the Stock Exchange on June 30, 2020.",positive,neutral,11.24553203189443,positive,-0.8684863523573202,neutral
2020-06-11 17:03:00.000,195.1,217.4,195.0,214.75,11911440.0,Granules surges over 13% so far this week; trades at a premium from buyback offer,"Granules India tabled its buyback offer for subscription from June 08, 2020.",positive,neutral,10.07175807278319,positive,-4.175317185697814,negative
2020-07-02 07:34:15.000,213.7,216.8,206.6,208.1,1840490.0,"In Pics | Stocks In The News: Ashok Leyland, JSPL, Tata Motors, JSW Energy, NMDC",Eveready Industries | Anup Engineering | Somany Ceramics | Urja Global | Polycab India | Granules India | Indian Bank | TVS Motor Company are also in focus today.,neutral,neutral,-2.620496022461392,negative,-0.286669851887254,neutral
2020-07-02 09:42:00.000,213.7,216.8,206.6,208.1,1840490.0,Granules India’s promoters including MD Krishna Prasad Chigurupati reduce 12.95% of their pledged shares,"Post announcement, the Granules stock ended at Rs207.45 per piece down by 2.17% on Sensex.",neutral,negative,-2.620496022461392,negative,-0.286669851887254,neutral
2020-07-03 05:30:00.000,209.3,214.0,207.5,208.7,2431559.0,"BRIEF-Granules India Says Issues Voluntary Nationwide Recall Of Metformin Hydrochloride Extended-Release Tablets USP, 750 Mg - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.286669851887254,neutral,-0.7119126720455625,neutral
2020-07-09 14:44:00.000,228.5,240.0,227.6,234.05,10074110.0,"Granules India surges 7%, hits record high on heavy volumes",The trading volumes on the counter more-than-doubled with a combined 6.6 million shares changing hands on the NSE and BSE till 02:43 pm,positive,positive,2.4288840262582108,positive,3.2176121930567416,positive
2020-07-16 16:05:00.000,248.75,267.9,243.65,263.0,17693382.0,"Share Market Highlights: Sensex ends 419 points, Nifty at 10,739; Infosys, BPCL, M&M, Cipla top gainers","Stock Market Highlights on July 16: Balkrishna Industries, Britannia Industries, Granules India and ICICI General Insurance are among the top companies that will be reporting their April-June quarterly earnings",neutral,neutral,5.728643216080402,positive,-0.4876219054763733,neutral
2020-07-17 05:30:00.000,248.75,267.9,243.65,263.0,17693382.0,BRIEF-Granules India Reports Higher Profit in June Qtr - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,5.728643216080402,positive,-0.4876219054763733,neutral
2020-07-17 08:12:00.000,248.75,267.9,243.65,263.0,17693382.0,"Board Meetings Today: Britannia, HCL Tech, ICICI Lombard, and Hathway Cable - The Economic Times","Coffee Day Enterprises, Granules India, Britannia, HCL Tech, are scheduled to announce their quarterly results today.",neutral,neutral,5.728643216080402,positive,-0.4876219054763733,neutral
2020-07-17 09:12:37.000,248.75,267.9,243.65,263.0,17693382.0,"Stocks in focus: HCL Tech, Britannia, GAIL, Oil India, IndiGo, SpiceJet, SBI Cards, Marico, PTC India","ICICI Lombard, Coffee Day Enterprises, Granules India, Hathway Cable, HCL Technologies, Britannia Industries are among 32 companies that scheduled to announce their quarterly earnings later in the day today.",neutral,neutral,5.728643216080402,positive,-0.4876219054763733,neutral
2020-07-17 12:30:00.000,248.75,267.9,243.65,263.0,17693382.0,Granules India Q1FY21 results; consolidated net profit increased by ~34% yoy,The company recorded a consolidated net profit of Rs111.45cr in Q1FY21.,positive,positive,5.728643216080402,positive,-0.4876219054763733,neutral
2020-07-17 12:45:00.000,248.75,267.9,243.65,263.0,17693382.0,Granules India climbs after Q1 PAT jumps 34% to Rs 111 cr,Granules India rose 3.48% to Rs 254.50 after the companys consolidated net profit jumped 34% to Rs 111.44 crore on 23.6% increase in revenue from operations to Rs 735.59 crore in Q1 June 2020 over Q1 June 2019.,positive,positive,5.728643216080402,positive,-0.4876219054763733,neutral
2020-07-17 12:48:00.000,248.75,267.9,243.65,263.0,17693382.0,Granules India shares hit new high after Q1 profit jumps 34%,The company’s consolidated net profit rose 34 percent to Rs 111.4 crore against Rs 83.2 crore YoY. Its consolidated revenue went up 23.6 percent at Rs 735.6 crore against Rs 595.3 crore YoY.,positive,positive,5.728643216080402,positive,-0.4876219054763733,neutral
2020-07-17 12:53:00.000,248.75,267.9,243.65,263.0,17693382.0,Granules India consolidated net profit rises 33.89% in the June 2020 quarter,Sales rise 23.57% to Rs 735.60 crore,positive,positive,5.728643216080402,positive,-0.4876219054763733,neutral
2020-07-17 12:54:00.000,248.75,267.9,243.65,263.0,17693382.0,"Granules India surges 8%, hits new high on strong June quarter results","In Q1FY21, Granules Indias Ebitda margin improved 503 basis points to 25 per cent",positive,positive,5.728643216080402,positive,-0.4876219054763733,neutral
2020-07-17 15:39:00.000,248.75,267.9,243.65,263.0,17693382.0,Granules India Q1 results: Net profit rises 34% to Rs 111.4 crore,Its consolidated revenue from operations stood at Rs 735.59 crore for the quarter under consideration.,positive,neutral,5.728643216080402,positive,-0.4876219054763733,neutral
2020-07-17 16:08:00.000,248.75,267.9,243.65,263.0,17693382.0,Granules India Q1 net profit rises 34% to Rs 111.4 crore,"The company had posted a net profit of Rs 83.24 crore for the corresponding period of the previous financial year, Granules India said in a filing to the BSE.",positive,positive,5.728643216080402,positive,-0.4876219054763733,neutral
2020-07-17 20:17:41.000,248.75,267.9,243.65,263.0,17693382.0,Granules India Q1 net profit rises 34 per cent to ₹111 cr,"Drug firm Granules India on Friday reported a 33.87 per cent rise in its consolidated net profit to ₹111.44 crore for the quarter ended June 30, 2020, mainly on account of robust sales.The company had",positive,positive,5.728643216080402,positive,-0.4876219054763733,neutral
2020-07-17 22:43:56.000,248.75,267.9,243.65,263.0,17693382.0,Granules Q1 net jumps 34% to ₹111.4 crore,"Drugmaker Granules India has reported a consolidated net profit of ₹111.44 crore for the quarter ended June 30, an increase of 34% from the year-earlier period.Revenue from operations at ₹735.59 crore",positive,positive,5.728643216080402,positive,-0.4876219054763733,neutral
2020-07-19 12:27:32.000,266.6,274.0,263.0,265.3,6452635.0,Motilal Oswal: Granules India A Quarter Of Record High Revenue Ebitda/PAT,Motilal Oswal: Granules India A Quarter Of Record High Revenue Ebitda/PAT,neutral,neutral,-0.4876219054763733,neutral,-1.1235955056179776,negative
2020-07-20 10:42:00.000,266.6,274.0,263.0,265.3,6452635.0,"Buy Granules India, target Rs 340: Emkay Global","Current quarter GMs are largely sustainable, as per management, and should help drive a 30% increase in PAT in FY21.",neutral,positive,-0.4876219054763733,neutral,-1.1235955056179776,negative
2020-07-20 11:52:00.000,266.6,274.0,263.0,265.3,6452635.0,"D-Street Buzz: Pharma stocks trade mixed; Glenmark, Sun Pharma slip, Granules India edges higher","Glenmark Pharma was down over 3 percent followed by Sun Pharma, Lupin, Aurobindo Pharma, Cipla and Biocon.",positive,negative,-0.4876219054763733,neutral,-1.1235955056179776,negative
2020-07-20 12:14:00.000,267.0,272.0,261.4,264.0,2982500.0,Buy Granules India ; target of Rs 315: Motilal Oswal,"Motilal Oswal is bullish on Granules India recommended buy rating on the stock with a target price of Rs 765 in its research report dated July 18, 2020.",neutral,positive,-1.1235955056179776,negative,1.9578313253012003,positive
2020-07-21 11:50:00.000,267.0,272.0,261.4,264.0,2982500.0,"Buy Granules India, target price Rs 330: Anand Rathi",Sales of formulations grew 35.2% to Rs 3.9bn (52% of sales) due to higher demand for existing products.,neutral,positive,-1.1235955056179776,negative,1.9578313253012003,positive
2020-07-21 13:43:00.000,265.6,276.4,263.05,270.8,6409335.0,Buy Granules India; target of Rs 340: Emkay Global Financial,"Emkay Global Financial is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 340 in its research report dated July 17, 2020.",neutral,positive,1.9578313253012003,positive,4.0503051599778015,positive
2020-07-21 13:55:00.000,265.6,276.4,263.05,270.8,6409335.0,Buy Granules India; target of Rs 327: Geojit,"Geojit recommended is bullish on Granules India recommended buy rating on the stock with a target price of Rs 327 in its research report dated July 20, 2020.",neutral,positive,1.9578313253012003,positive,4.0503051599778015,positive
2020-07-21 18:05:00.000,265.6,276.4,263.05,270.8,6409335.0,Buy Granules India; target of Rs 330: Anand Rathi,"Anand Rathi recommended hold rating on Granules India with a target price of Rs 330 in its research report dated July 20, 2020.",neutral,positive,1.9578313253012003,positive,4.0503051599778015,positive
2020-07-22 06:41:00.000,265.6,276.4,263.05,270.8,6409335.0,Broker’s call: Granules India (Buy),"Centrum BrokingGranules India (Buy) Target: ₹315CMP: ₹264.45Amid the extraordinary times, Granules India posted record quarterly performance well ahead of our estimates. The record quarterly performan",neutral,positive,1.9578313253012003,positive,4.0503051599778015,positive
2020-07-26 15:16:00.000,301.5,308.8,282.25,293.35,9917871.0,"Lupin, Granules India recall 971,000 diabetes drug bottles from US market","As per the USFDA, the companies are recalling the product due to deviation from the current good manufacturing practices",neutral,negative,-2.7031509121061283,negative,-1.070882202957667,negative
2020-07-26 15:26:05.000,301.5,308.8,282.25,293.35,9917871.0,"Lupin, Granules India recall 9.71 lakh bottles of diabetes drug in US market","As per the USFDA, Lupin and Granules India are recalling the generic diabetes drugs due to deviation from the current good manufacturing practices",negative,negative,-2.7031509121061283,negative,-1.070882202957667,negative
2020-07-26 15:30:49.000,301.5,308.8,282.25,293.35,9917871.0,"Lupin, Granules India Recall Around 9.71 Lakh Bottles Of Diabetes Drug In U.S.",The affected lot is suspected of having cancer-causing nitrosodimethylamine above the acceptable intake limit.,neutral,neutral,-2.7031509121061283,negative,-1.070882202957667,negative
2020-07-26 16:42:00.000,301.5,308.8,282.25,293.35,9917871.0,"Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US market","As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Lupin is recalling 4,92,858 bottles of Metformin Hydrochloride extended-release tablets in 500 mg and 1,000 strengths.",negative,negative,-2.7031509121061283,negative,-1.070882202957667,negative
2020-07-26 19:26:15.000,301.5,308.8,282.25,293.35,9917871.0,"Lupin, Granules India Recall 9.71 Lakh Bottles of Diabetes Drug in US Market","According to the USFDA, Lupin is recalling 4,92,858 bottles of Metformin Hydrochloride extended-release tablets in 500 mg and 1,000 mg strengths, while Hydera.",neutral,negative,-2.7031509121061283,negative,-1.070882202957667,negative
2020-07-26 19:39:17.000,301.5,308.8,282.25,293.35,9917871.0,"Lupin, Granules India recall 9.71 lakh bottles of diabetes drug in the US market",Drug makers Lupin and Granules India are recalling close to 9.71 lakh bottles of generic diabetes drug in the US due to possibility of the affected lot containing cancer causing nitrosodimethylamine (,negative,negative,-2.7031509121061283,negative,-1.070882202957667,negative
2020-07-26 21:27:34.000,301.5,308.8,282.25,293.35,9917871.0,"Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US market","Lupin is recalling 1,23,912 bottles of the 500 mg Metformin Hydrochloride extended-release tablets and 3,68,946 bottles of the same drug of 1,000 mg strength.",negative,negative,-2.7031509121061283,negative,-1.070882202957667,negative
2020-07-27 05:30:00.000,301.5,308.8,282.25,293.35,9917871.0,BRIEF-Granules India Says There Has Been No Additional Recall Since July 3 Recall - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-2.7031509121061283,negative,-1.070882202957667,negative
2020-08-03 12:16:09.000,301.0,309.45,296.85,302.7,5691975.0,Amber Enterprises India Ltd leads gainers in ‘A’ group,"Laurus Labs Ltd, Granules India Ltd, Ratnamani Metals & Tubes Ltd and Dixon Technologies (India) Ltd are among the other gainers in the BSEs A group today, 03 August 2020.",positive,neutral,0.5647840531561423,neutral,3.9678635841941374,positive
2020-08-24 08:17:00.000,320.0,324.35,316.2,318.5,2425855.0,"Stocks in the news: SBI, ICICI Lombard, LIC Housing, Granules India, Lupin, BHEL and Union Bank","NOCIL, Scooters India and Globus Spirits are among of the companies which will announce their June quarter results today.",neutral,neutral,-0.46875,neutral,-2.903074761979089,negative
2020-08-24 09:48:00.000,320.0,324.35,316.2,318.5,2425855.0,Granules India announces receipt of USFDA approval for Ramelteon Tablets,Granules now has a total of 29 ANDA approvals from US FDA (27 Final approvals and 2 tentative approvals).,positive,neutral,-0.46875,neutral,-2.903074761979089,negative
2020-08-24 12:18:00.000,320.35,321.3,310.0,311.05,1815978.0,Granules India rises 3% on USFDA nod to insomnia drug,"The company now has a total of 29 ANDA approvals from USFDA (27 final approvals and 2 tentative approvals), Granules India said.",neutral,positive,-2.903074761979089,negative,-1.3694267515923604,negative
2020-08-24 22:58:08.000,320.35,321.3,310.0,311.05,1815978.0,USFDA nod for Granules insomnia tablets,"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals Inc., a subsidiary of Granules India, for Ramelteon tablets, 8 mg",neutral,positive,-2.903074761979089,negative,-1.3694267515923604,negative
2020-08-27 17:14:00.000,312.0,315.5,308.0,310.2,2054217.0,How Granules India transformed itself from a company making commodity APIs into one making formulations,"Company puts interim, long-term strategies in place to beat the pricing pressure in the US market and build a sustainable generics business. Currently, the US business contributes about 52 percent to the Granules’ total revenues.",positive,positive,-0.5769230769230806,neutral,0.608876782566889,neutral
2020-09-04 14:25:00.000,320.0,350.0,315.5,347.7,10025256.0,"Granules India rallies 8% in a weak market, hits fresh all-time high","The stock hit a record high of Rs 350 today. It has surged 13% thus far in the current week, as compared to a 2% decline in the S&P BSE Sensex",positive,positive,8.656249999999996,positive,6.957513544339903,positive
2020-09-07 12:16:09.000,374.5,382.0,355.35,356.95,7550764.0,Tata Motors-DVR leads gainers in ‘A’ group,"WABCO India Ltd, Himatsingka Seide Ltd, T.V. Today Network Ltd and Granules India Ltd are among the other gainers in the BSEs A group today, 07 September 2020.",positive,positive,-4.686248331108147,negative,4.726332423502367,positive
2020-09-10 14:47:00.000,365.0,372.85,341.35,347.45,8430609.0,Granules India hits fresh record high of Rs 384; rallies 24% in 2 weeks,Analysts expect launches in formulations and additional capacity in pharmaceutical formulation intermediate (PFIs) to be key growth drivers,positive,positive,-4.808219178082196,negative,6.048158640226635,positive
2020-09-11 05:30:00.000,365.0,372.85,341.35,347.45,8430609.0,BRIEF-Granules India Gets FDA Nod For ADHD Drug - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-4.808219178082196,negative,6.048158640226635,positive
2020-09-11 08:48:00.000,365.0,372.85,341.35,347.45,8430609.0,Granules India’s US subsidiary gets USFDA nod attention deficit hyperactivity disorder drug,"Granules’ capsule product is bioequivalent to the reference listed drug (RLD), Focalin XR.",neutral,neutral,-4.808219178082196,negative,6.048158640226635,positive
2020-09-11 09:15:00.000,365.0,372.85,341.35,347.45,8430609.0,Granules spurts after USFDA nod for ADHD drug,Granules India gained 4.68% to Rs 378 after the pharmaceutical company announced that its US subsidiary has received marketing approval from the USFDA for Dexmethylphenidate HCI extended-release capsules.,neutral,positive,-4.808219178082196,negative,6.048158640226635,positive
2020-09-11 09:20:00.000,365.0,372.85,341.35,347.45,8430609.0,Granules India receives USFDA approval for Dexmethylphenidate HCI ER capsules,"The drug will be manufactured at the Granules manufacturing facility in Chantilly, Virginia.",positive,neutral,-4.808219178082196,negative,6.048158640226635,positive
2020-09-11 12:17:14.000,365.0,372.85,341.35,347.45,8430609.0,Granules India gains 5% on US FDA approval for ADHD drug,"The drug will be manufactured at the Granules manufacturing facility in Chantilly, Virginia. The company now has a total of 30 ANDA approvals from the USFDA, of which 28 are final approvals and 2 are tentative.",positive,neutral,-4.808219178082196,negative,6.048158640226635,positive
2020-09-11 15:16:15.000,365.0,372.85,341.35,347.45,8430609.0,Amber Enterprises India Ltd leads losers in ‘A’ group,"Granules India Ltd, Bank of India, PVR Ltd and KNR Constructions Ltd are among the other losers in the BSEs A group today, 11 September 2020.",positive,negative,-4.808219178082196,negative,6.048158640226635,positive
2020-09-14 12:35:00.000,377.7,379.0,361.65,369.3,4055604.0,Buy Granules India; target of Rs 410: Motilal Oswal,"Motilal Oswal is bullish on Granules India recommended buy rating on the stock with a target price of Rs 410 in its research report dated September 12, 2020.",neutral,positive,-2.2239872915011856,negative,-0.8756567425569177,neutral
2020-09-15 20:19:17.000,371.15,374.8,365.0,367.9,2146089.0,ICICI Direct: Granules India’s Strong Integrated Model To Support Volume Play,Granules India is seen well-poised to extend its core strength and launch niche drugs besides volume-based legacy ones.,neutral,positive,-0.8756567425569177,neutral,-0.8453776929369964,neutral
2020-09-25 05:30:00.000,395.0,395.0,370.05,378.15,7741187.0,BRIEF-Granules India Gets U.S. FDA Nod For Generic Aleve PM Tablets - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-4.265822784810132,negative,4.425587467362922,positive
2020-09-25 07:24:00.000,395.0,395.0,370.05,378.15,7741187.0,"Hot Stocks | Apollo Hospitals, Wipro, Granules India three buy calls for short-term","The index is trading near 261.8 percent Fibonacci projected level, based on the previous week’s trading range, suggesting that bears might take a breather.",neutral,neutral,-4.265822784810132,negative,4.425587467362922,positive
2020-09-25 10:09:00.000,395.0,395.0,370.05,378.15,7741187.0,Granules India shares hit 52-week high as global equity firms eye controlling stake,"KKR, Bain Capital and Blackstone have expressed interest in acquiring a controlling stake in the company.",positive,neutral,-4.265822784810132,negative,4.425587467362922,positive
2020-09-25 10:12:00.000,395.0,395.0,370.05,378.15,7741187.0,"Granules India stock zooms on report KKR, Bain in line to pick stake","Further, the media statement added that on September 10, the promoter family of Granules India had revived plans for a potential exit from the company and was evaluating the sale of a majority stake at a premium valuation.",neutral,positive,-4.265822784810132,negative,4.425587467362922,positive
2020-09-25 11:15:00.000,395.0,395.0,370.05,378.15,7741187.0,Granules India surges 10% as three PE firms look to pick controlling stake,"A media report said that Blackstone, KKR and Bain Capital have submitted non-binding bids for the proposed transaction and investment bank Kotak Mahindra Capital has been engaged by the promoters of Granules India to look for buyers.",positive,positive,-4.265822784810132,negative,4.425587467362922,positive
2020-09-25 11:29:00.000,395.0,395.0,370.05,378.15,7741187.0,Granules India climbs after USFDA nod for generic,"Granules India rose 3.92% to Rs 374.75 after the company said it received US drug regulators approval of Naproxen Sodium and Diphenhydramine Hydrochloride tablets, 220 mg/25 mg (OTC).",positive,positive,-4.265822784810132,negative,4.425587467362922,positive
2020-09-25 11:42:00.000,395.0,395.0,370.05,378.15,7741187.0,Granules India receives USFDA approval for generic Aleve PM Tablets,Naproxen Sodium and Diphenhydramine Hydrochloride Tablets are used for relief of occasional sleeplessness associated with minor aches and pains and to help you fall asleep and stay asleep.,positive,neutral,-4.265822784810132,negative,4.425587467362922,positive
2020-09-25 12:20:00.000,395.0,395.0,370.05,378.15,7741187.0,Granules India up 5% on USFDA approval for generic Aleve PM tablets,"According to media reports, global private equity firms have expressed interest in acquiring a controlling stake in the company",positive,neutral,-4.265822784810132,negative,4.425587467362922,positive
2020-09-25 16:40:00.000,395.0,395.0,370.05,378.15,7741187.0,Granules India gets USFDA nod for sleep aid drug,"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) for Naproxen Sodium and Diphenhydramine Hydrochloride tablets, 220 mg/25 mg (OTC), Granules said in a BSE filing.",neutral,positive,-4.265822784810132,negative,4.425587467362922,positive
2020-09-25 20:05:28.000,395.0,395.0,370.05,378.15,7741187.0,Granules India shares gain on stake sale buzz,The company also received approval from USFDA for sleeping pills,positive,positive,-4.265822784810132,negative,4.425587467362922,positive
2020-09-25 21:14:15.000,395.0,395.0,370.05,378.15,7741187.0,Granules India jumps on stake sale buzz,"Can’t confirm or deny news, firm tells BSE",neutral,neutral,-4.265822784810132,negative,4.425587467362922,positive
2020-10-20 05:30:00.000,392.0,404.0,382.5,391.0,6366567.0,BRIEF-Granules India Sept-Quarter Consol Profit Rises - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.2551020408163265,neutral,-2.870813397129195,negative
2020-10-20 11:09:00.000,392.0,404.0,382.5,391.0,6366567.0,"Important results today: Hindustan Unilever, L&T Infotech, Hindustan Zinc","DCM Shriram, Granules India, Hindustan Zinc,
Indian Energy Exchange will announce their quarterly earnings on October 20.",neutral,neutral,-0.2551020408163265,neutral,-2.870813397129195,negative
2020-10-20 12:30:00.000,397.1,403.8,382.0,385.7,2338216.0,Granules India Q2 profits up 70% yoy at Rs164cr,Granules India reported stellar results for the Sep-20 quarter. The total sales revenues were up by 22.7% at Rs858cr and the sales were also up 16.6% on a sequential basis.,positive,positive,-2.870813397129195,negative,1.4322916666666663,positive
2020-10-20 12:54:00.000,397.1,403.8,382.0,385.7,2338216.0,Granules India consolidated net profit rises 70.82% in the September 2020 quarter,Sales rise 22.67% to Rs 858.12 crore,positive,positive,-2.870813397129195,negative,1.4322916666666663,positive
2020-10-20 13:03:23.000,397.1,403.8,382.0,385.7,2338216.0,Granules India’s Q2 net surges 71% to ₹164 crore,Drug maker reports 23% rise in revenues,positive,positive,-2.870813397129195,negative,1.4322916666666663,positive
2020-10-20 13:29:00.000,397.1,403.8,382.0,385.7,2338216.0,Granules India Q2 PAT spurts 71% to Rs 164 cr,The pharma company reported 70.8% jump in consolidated net profit to Rs 164 crore on a 22.7% rise in income from operations to Rs 858 crore in Q2 FY21 over Q2 FY20.,neutral,positive,-2.870813397129195,negative,1.4322916666666663,positive
2020-10-20 16:43:00.000,397.1,403.8,382.0,385.7,2338216.0,Granules India Q2 results: Net profit surges 71% to Rs 164 cr,"Consolidated revenue from operations stood at Rs 858.12 crore for the quarter under consideration. It was Rs 699.53 crore in the same period a year ago, it added.",positive,neutral,-2.870813397129195,negative,1.4322916666666663,positive
2020-10-20 23:02:23.000,397.1,403.8,382.0,385.7,2338216.0,Granules India Q2 net profit surges 71% to Rs 164 crore,"Drug firm Granules India on Tuesday reported a 70.82 per cent rise in its consolidated net profit to Rs 163.63 crore for the second quarter ended September 30, mainly on account of robust sales.The company had posted a net profit of Rs 95.79 crore for the corresponding period previous fisc…",positive,positive,-2.870813397129195,negative,1.4322916666666663,positive
2020-10-21 08:39:04.000,397.1,403.8,382.0,385.7,2338216.0,Motilal Oswal: Granules India - Making Strong Headway,Motilal Oswal: Granules India - Making Strong Headway,neutral,neutral,-2.870813397129195,negative,1.4322916666666663,positive
2020-10-21 09:13:00.000,397.1,403.8,382.0,385.7,2338216.0,"Granules India Standalone September 2020 Net Sales at Rs 834.50 crore, up 30.64% Y-o-Y",,positive,neutral,-2.870813397129195,negative,1.4322916666666663,positive
2020-10-21 14:40:00.000,384.0,391.0,381.05,389.5,1350148.0,Buy Granules India; target of Rs 500: Motilal Oswal,"Motilal Oswal is bullish on Granules India recommended buy rating on the stock with a target price of Rs 500 in its research report dated October 20, 2020.",neutral,positive,1.4322916666666663,positive,-1.010359380995009,negative
2020-10-21 14:42:00.000,384.0,391.0,381.05,389.5,1350148.0,Buy Granules India Limited; target of Rs 475: Sharekhan,"Sharekhan is bullish on Granules India Limited has recommended buy rating on the stock with a target price of Rs 475 in its research report dated October 20, 2020.",neutral,positive,1.4322916666666663,positive,-1.010359380995009,negative
2020-10-22 10:12:00.000,384.0,391.0,381.05,389.5,1350148.0,Granules India receives USFDA marketing approval for Potassium Chloride ER Tablets,"The drug will be manufactured at the Granules manufacturing facility in Gagillapur, Hyderabad. Granules now
have a total of 34 ANDA approvals from the US FDA (32 Final approvals and 2 tentative approvals).",positive,neutral,1.4322916666666663,positive,-1.010359380995009,negative
2020-10-22 10:39:35.000,384.0,391.0,381.05,389.5,1350148.0,Granules India gets USFDA nod for generic hypokalemia drug,Granules India has received marketing approval from the US Food and Drug Administration (USFDA) for potassium chloride extended release tablets for the treatment of patients with hypokalemia. Granules,neutral,positive,1.4322916666666663,positive,-1.010359380995009,negative
2020-10-22 10:44:00.000,384.0,391.0,381.05,389.5,1350148.0,Granules rises after USFDA approval for generic drug,Granules India rose 1% to Rs 389.35 after the company received US drug regulators approval for generic potassium chloride tablets for the treatment of Hypokalemia.,positive,positive,1.4322916666666663,positive,-1.010359380995009,negative
2020-10-22 11:28:00.000,384.0,391.0,381.05,389.5,1350148.0,Granules India gets USFDA nod for potassium chloride tablets used to treat hypokalemia,"Granules has received marketing approval from the US Food and Drug Administration (USFDA) for Potassium Chloride extended release tablets USP in the strengths of 10 mEq (750 mg) and 20 mEq (1500 mg), the company said in a BSE filing.",neutral,positive,1.4322916666666663,positive,-1.010359380995009,negative
2020-10-22 11:49:00.000,384.0,391.0,381.05,389.5,1350148.0,Granules India gets USFDA approval for potassium chloride tablets,"Drug firm Granules India said it has received marketing approval from the US health regulator for Potassium Chloride extended release tablets, used for treatment of patients with hypokalemia",positive,positive,1.4322916666666663,positive,-1.010359380995009,negative
2020-10-22 14:22:00.000,390.95,392.7,385.0,387.0,786365.0,Buy Granules India; target of Rs 455: Anand Rathi,"Anand Rathi is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 455 in its research report dated October 22, 2020.",neutral,positive,-1.010359380995009,negative,-2.051282051282051,negative
2020-10-22 16:01:00.000,390.95,392.7,385.0,387.0,786365.0,Buy Granules India; target of Rs 459: KRChoksey,"KRChoksey is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 459 in its research report dated October 22, 2020.",neutral,positive,-1.010359380995009,negative,-2.051282051282051,negative
2020-10-22 23:10:42.000,390.95,392.7,385.0,387.0,786365.0,Granules’ potassium pill gets FDA nod,"Pharmaceutical manufacturer Granules India has received marketing approval from the U.S. Food and Drug Administration (USFDA) for Potassium Chloride Extended Release Tablets USP, 10 mEq (750 mg) and 2",neutral,positive,-1.010359380995009,negative,-2.051282051282051,negative
2020-10-27 18:52:06.000,385.5,386.85,376.2,378.5,726883.0,Two more drug firms to set shop in Genome Valley,"Our Bureau Drug-makers Granules India Ltd and Laurus Labs have announced independent plans to set up new manufacturing facilities in Genome Valley, Hyderabad.Granules India projectGranules India will",neutral,positive,-1.8158236057068744,negative,2.803738317757009,positive
2020-11-03 21:44:00.000,374.95,378.0,370.0,377.0,558219.0,Buy Granules India; target of Rs 460: ICICI Direct,"ICICI Direct is bullish on Granules India recommended buy rating on the stock with a target price of Rs 460 in its research report dated October 21, 2020.",neutral,positive,0.5467395652753732,neutral,-1.0426290088425616,negative
2020-11-09 05:30:00.000,372.1,387.35,366.0,387.0,1384782.0,BRIEF-Granules India To Incorporate Unit In Hyderabad - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,4.004299919376505,positive,-3.4487212606561672,negative
2020-11-09 12:09:38.000,387.1,388.4,369.0,373.75,1057536.0,Granules India board gives nod to set up subsidiary in Hyderabad,Company to build greenfield unit for formulations biz,neutral,neutral,-3.4487212606561672,negative,0.9408602150537636,positive
2020-11-09 17:42:00.000,387.1,388.4,369.0,373.75,1057536.0,Granules India stock trades flat; board gives nod to set up subsidiary in Hyderabad,"“The Board of Directors at their meeting has approved to incorporate a wholly-owned subsidiary of the Company in Hyderabad, India to build a green field facility for formulations business,” Granules said in the filing.",neutral,positive,-3.4487212606561672,negative,0.9408602150537636,positive
2020-11-23 10:52:00.000,374.35,401.0,374.35,400.55,2536552.0,"Pharma shares in focus; Divi’s Labs hits new high, Gland Pharma zooms 20%","Dishman Carbogen Amcis, Ipca Lab, SPARC, Caplin Point Laboratories, Dr. Lal PathLabs and Granules India from the S&P BSE Healthcare index were up in the range of 4 per cent to 5 per cent on the BSE",neutral,positive,6.998797916388404,positive,3.333333333333333,positive
2020-11-24 10:58:00.000,405.0,420.0,403.7,418.5,4181113.0,"Granules India shares gain 5%, hit record high on heavy volumes","In Q2FY21, the companys Ebitda grew 78.6 per cent YoY, with a 935 basis points margin expansion YoY on changing product mix and improved operational efficiencies",positive,positive,3.333333333333333,positive,-1.729857819905216,negative
2020-11-24 22:09:14.000,422.0,425.0,408.0,414.7,1824014.0,Granules India (₹418.6): Buy,"The stock of Granules India, which was moving in a sideways trend, broke out of the range on Tuesday, opening the door for further appreciation. Hence, traders looking for short-term opportunities can",neutral,positive,-1.729857819905216,negative,-0.9877138039026796,negative
2020-12-01 09:42:00.000,426.0,437.95,425.0,427.0,2853057.0,Granules India surges 6% on Carlyle group acquisition buzz,"Carlyle is expected to buy 42 per cent of promoter shares, which will trigger an open offer to acquire additional stake from others, CNBC TV18 report.",positive,positive,0.2347417840375587,neutral,-1.2149532710280349,negative
2020-12-01 10:30:00.000,426.0,437.95,425.0,427.0,2853057.0,Granules India jumps on buzz PE firm eyes stake,Granules India rose 3.81% to Rs 428.15 after the media reported that private equity firm Carlyle group is in advanced talks to acquire the pharmaceutical firm for around $1 billion.,neutral,positive,0.2347417840375587,neutral,-1.2149532710280349,negative
2020-12-03 05:30:00.000,422.9,425.45,418.0,418.95,504218.0,BRIEF-Granules India Announces Approval Of Penicillamine Capsules - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.934026956727356,negative,-1.1260997067448706,negative
2020-12-03 09:45:00.000,422.9,425.45,418.0,418.95,504218.0,"Granules India announces USFDA approval of Penicillamine Capsules, 250 mg","The new drug is generic equivalent of Cuprimine of Bausch Health Americas, Inc.",positive,neutral,-0.934026956727356,negative,-1.1260997067448706,negative
2020-12-03 17:39:00.000,426.25,429.9,420.0,421.45,1135515.0,"Granules India receives USFDA approval for Penicillamine Capsules USP, 250 mg","Penicillamine Capsules are indicated in the treatment of Wilson’s disease, cystinuria, and in patients with severe, active rheumatoid arthritis who have failed to respond to an adequate trial of conventional therapy.",positive,neutral,-1.1260997067448706,negative,-6.925436526663526,negative
2020-12-03 18:48:39.000,426.25,429.9,420.0,421.45,1135515.0,Granules gets USFDA’s nod for Penicillamine Capsules,Granules India Limited has received approval from the US Food &amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Penicillamine Capsules. It is bioequivalent to t,neutral,positive,-1.1260997067448706,negative,-6.925436526663526,negative
2020-12-04 08:08:23.000,426.25,429.9,420.0,421.45,1135515.0,"Stocks To Watch: Bank of India, GHCL, Granules India, Orient Cement, PNB, Vedanta",Here are the stocks to watch in trade today.,neutral,neutral,-1.1260997067448706,negative,-6.925436526663526,negative
2020-12-04 08:50:00.000,426.25,429.9,420.0,421.45,1135515.0,"Stocks to watch: HDFC Bank, Voda Idea, rate-sensitive stks, Granules India",Heres a list of stocks that may trade actively in todays session.,neutral,neutral,-1.1260997067448706,negative,-6.925436526663526,negative
2020-12-04 08:57:00.000,426.25,429.9,420.0,421.45,1135515.0,Granules India gets USFDA approval for Penicillamine capsules,"The US Food & Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI), a wholly-owned foreign subsidiary of Granules India, for Penicillamine capsules USP, 250 mg.",positive,positive,-1.1260997067448706,negative,-6.925436526663526,negative
2020-12-04 09:40:46.000,426.25,429.9,420.0,421.45,1135515.0,"Granules India shares gain on US FDA approval for generic of Cuprimine, Penicillamine capsules","Granules India announced that the US FDA has approved the ANDA filed by Granules Pharmaceuticals, Inc (GPI)., for Penicillamine Capsules USP, 250 mg, the company said in an exchange filing.",positive,positive,-1.1260997067448706,negative,-6.925436526663526,negative
2020-12-04 10:15:00.000,426.25,429.9,420.0,421.45,1135515.0,"Stocks in news: NCC, Union Bank, Granules India, GHCL, HDFC Life, NMDC","Stocks to watch today on December 4: NCC, Union Bank, Granules India, GHCL, HDFC Life, NMDC among others are the top stocks to watch out for in Friday’s trading session",neutral,neutral,-1.1260997067448706,negative,-6.925436526663526,negative
2020-12-04 12:55:00.000,426.25,429.9,420.0,421.45,1135515.0,"Top stocks in focus: PSU Banks, Granules India, HDFC Life, Bharti Airtel, Vedanta, Adani Enterprises",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-1.1260997067448706,negative,-6.925436526663526,negative
2020-12-07 15:04:33.000,395.5,398.0,381.0,387.0,2131097.0,Granules India Ltd leads losers in ‘A’ group,"Astral Poly Technik Ltd, Adani Power Ltd, Tata Steel Ltd Partly Paid Up and Varroc Engineering Ltd are among the other losers in the BSEs A group today, 07 December 2020.",negative,negative,-2.149178255372945,negative,2.577521915478221,positive
2020-12-08 14:26:00.000,382.15,394.0,381.3,392.0,969136.0,"D-Street up for 6th day, but Vodafone Idea, BPCL, 45 other stocks sending out sell signal","BPCL, Granules India, SBI Life Insurance, Adani Gas, Bajaj Holdings, Jindal Stainless and Bajaj Holdings were among stocks hinting at possible weakness on MACD indicator.",positive,neutral,2.577521915478221,positive,-0.5612244897959154,neutral
2021-01-07 15:29:58.000,369.0,370.1,365.5,365.5,920410.0,Buy Granules India: Target Of Rs 475: Sharekhan,"Sharekhan is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 475 in its research report dated January 06, 2020.",neutral,positive,-0.9485094850948508,negative,-1.626236617427836,negative
2021-01-13 09:10:00.000,361.1,371.9,361.1,368.0,2219838.0,Granules India receives USFDA approval for Metformin Hydrochloride ER Tablets USP,"Glumetza is a trademark of Salix Pharmaceuticals, Inc. or its affiliates.",positive,neutral,1.9108280254777008,positive,-2.0107238605898123,negative
2021-01-13 12:00:00.000,361.1,371.9,361.1,368.0,2219838.0,Granules India climbs after USFDA approval for type 2 diabetes drug,"Granules India gained 2.21% to Rs 369.50 after the company said it received US drug regulators approval of metformin hydrochloride ER tablets USP, 500 mg and 1000 mg.",positive,positive,1.9108280254777008,positive,-2.0107238605898123,negative
2021-01-13 12:48:49.000,373.0,376.85,365.0,365.5,2025991.0,Granules India Share Price Up 3% On USFDA Approval,"The share touched its 52-week high Rs 438.00 and 52-week low Rs 114.50 on 01 December, 2020 and 23 March, 2020, respectively.",neutral,positive,-2.0107238605898123,negative,-2.602534405232324,negative
2021-01-13 12:50:05.000,373.0,376.85,365.0,365.5,2025991.0,Granules India receives USFDA approval,For Metformin Hydrochloride ER Tablets USP,positive,neutral,-2.0107238605898123,negative,-2.602534405232324,negative
2021-01-13 15:14:01.000,373.0,376.85,365.0,365.5,2025991.0,Granules India gets USFDA nod for Metformin Hydrochloride tablets,Drug is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus; had US sales of about $192 mn for 12 months ending November 2020,neutral,neutral,-2.0107238605898123,negative,-2.602534405232324,negative
2021-01-28 05:30:00.000,356.0,366.9,347.05,351.9,3149233.0,BRIEF-Granules India Dec-Qtr Consol Profit Rises,BRIEF-Granules India Dec-Qtr Consol Profit Rises,neutral,neutral,-1.1516853932584332,negative,-5.035360678925038,negative
2021-01-28 06:35:00.000,356.0,366.9,347.05,351.9,3149233.0,Granules India Q3 PAT up more than doubles to Rs146.81cr on sales boost,Granules India reported 19.97% growth in total revenues for the Dec-20 quarter on consolidated basis at Rs844.51cr,positive,positive,-1.1516853932584332,negative,-5.035360678925038,negative
2021-01-28 13:34:00.000,353.5,353.5,335.2,335.7,1847575.0,Granules India consolidated net profit rises 129.28% in the December 2020 quarter,Sales rise 19.97% to Rs 844.51 crore,positive,positive,-5.035360678925038,negative,-3.4467455621301704,negative
2021-01-28 22:51:35.000,353.5,353.5,335.2,335.7,1847575.0,Granules net more than doubles to ₹147 cr.,Pharma manufacturing company Granules India has posted a consolidated net profit of ₹147 crore for the quarter ended December 31 compared with ₹64 crore in the year-earlier period. The firm has declar,positive,positive,-5.035360678925038,negative,-3.4467455621301704,negative
2021-01-29 11:46:00.000,353.5,353.5,335.2,335.7,1847575.0,"Buy Granules India, target price Rs 460: Motilal Oswal","Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 8471.72 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-5.035360678925038,negative,-3.4467455621301704,negative
2021-01-29 19:13:35.000,353.5,353.5,335.2,335.7,1847575.0,Buy Granules India; Target Of Rs 475: Sharekhan,"Sharekhan is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 475 in its research report dated January 28, 2021.",neutral,positive,-5.035360678925038,negative,-3.4467455621301704,negative
2021-01-29 21:36:50.000,353.5,353.5,335.2,335.7,1847575.0,Granules Q3 net profit more than doubles to ₹147 cr,"Granules India Ltd's consolidated net profit more than doubled at ₹147 crore in the third quarter ended December 31, 2020 against ₹64 crore in the corresponding quarter of the previous financial y",positive,positive,-5.035360678925038,negative,-3.4467455621301704,negative
2021-02-01 05:30:00.000,338.0,338.0,324.0,326.35,1460468.0,BRIEF-Granules India Says Gets Approval Of Potassium Chloride Oral Solution Usp,BRIEF-Granules India Says Gets Approval Of Potassium Chloride Oral Solution Usp,neutral,neutral,-3.4467455621301704,negative,-3.1969696969697003,negative
2021-02-01 08:19:00.000,338.0,338.0,324.0,326.35,1460468.0,Granules India receives USFDA approval for Potassium Chloride Oral Solution USP,"The company announced approval of Potassium Chloride Oral Solution USP, generic equivalent of Potassium Chloride Oral Solution of Genus Lifesciences, Inc..",positive,positive,-3.4467455621301704,negative,-3.1969696969697003,negative
2021-02-01 10:22:00.000,338.0,338.0,324.0,326.35,1460468.0,Granules India receives USFDA approval for Potassium Chloride Oral Solution,"It is bioequivalent to the reference listed drug product (RLD), Potassium Chloride
Oral Solution, 20 mEq/15 mL (10%) and 40 mEq/15 mL (20%), of Genus Lifesciences, Inc.",positive,neutral,-3.4467455621301704,negative,-3.1969696969697003,negative
2021-02-01 10:46:00.000,338.0,338.0,324.0,326.35,1460468.0,Granules arm gets American health regulator’s nod for Potassium Chloride Oral Solution,"In a BSE filing, Granules said the US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI), a wholly-owned foreign subsidiary of Granules India Ltd, for Potassium Chloride Oral Solution USP.",neutral,positive,-3.4467455621301704,negative,-3.1969696969697003,negative
2021-02-01 11:40:00.000,338.0,338.0,324.0,326.35,1460468.0,Granules India gets USFDA nod for generic potassium chloride oral solution,"The US drug regulator has approved the ANDA filed by Granules Pharmaceuticals, Inc, a wholly owned foreign arm of Granules India, for potassium chloride oral solution USP, 20 mEq/15 mL (10%) and 40 mEq/15 mL (20%).",neutral,positive,-3.4467455621301704,negative,-3.1969696969697003,negative
2021-02-03 20:48:53.000,344.0,356.0,344.0,348.0,2056789.0,Buy Granules India; Target Of Rs 460: Motilal Oswal,"Motilal Oswal is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 460 in its research report dated January 28, 2021.",neutral,positive,1.162790697674419,positive,-3.6714285714285775,negative
2021-02-04 17:22:40.000,350.0,350.0,335.7,337.15,1381695.0,Buy Granules India; Target Of Rs 460: ICICI Direct,"ICICI Direct is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 460 in its research report dated January 29, 2021.",neutral,positive,-3.6714285714285775,negative,-2.061855670103093,negative
2021-02-09 04:03:00.000,331.95,333.8,326.25,328.1,1164939.0,Granules India to invest ₹800 cr. in expansion,Drugmaker eyes facility abroad,positive,neutral,-1.1598132248832551,negative,1.441441441441445,positive
2021-02-17 05:30:00.000,351.75,353.1,340.0,341.5,1441586.0,BRIEF-Granules India Says Gets Approval Of Potassium Chloride ER Capsules USP,BRIEF-Granules India Says Gets Approval Of Potassium Chloride ER Capsules USP,neutral,neutral,-2.9140014214641083,negative,-2.1979621542940357,negative
2021-02-17 13:43:00.000,343.5,344.0,335.0,335.95,1552361.0,Granules India receives USFDA approval for Potassium Chloride ER Capsules,"Potassium Chloride is indicated for the treatment of patients with hypokalemia with or without metabolic
alkalosis, in digitalis intoxications, and in patients with hypokalemic familial periodic paralysis.It is also
indicated for the prevention of",positive,neutral,-2.1979621542940357,negative,-1.4294222751637915,negative
2021-02-17 14:37:00.000,343.5,344.0,335.0,335.95,1552361.0,Granules India gets USFDA nod for potassium chloride capsules,"The US drug regulator has approved the drug maker’s abbreviated new drug application (ANDA) for potassium chloride extended-release capsules USP, 8 mEq (600 mg) and 10 mEq (750 mg).",neutral,positive,-2.1979621542940357,negative,-1.4294222751637915,negative
2021-02-17 15:56:52.000,343.5,344.0,335.0,335.95,1552361.0,USFDA nod for Granules Potassium Chloride ER Capsules,"The US Food and Drug Administration (USFDA) has approved drugmaker Granules India’s Abbreviated New Drug Application (ANDA) for Potassium Chloride Extended-Release Capsules USP, 8 mEq (600 mg) and 10",neutral,positive,-2.1979621542940357,negative,-1.4294222751637915,negative
2021-02-17 16:41:57.000,343.5,344.0,335.0,335.95,1552361.0,Granules India gets USFDA nod for its Potassium Chloride ER Capsules USP,"Granules India Limited has announced that the US Food &amp; Drug Administration has approved its Abbreviated New Drug Application (ANDA) for Potassium Chloride Extended-Release Capsules USP, 8 mEq",neutral,positive,-2.1979621542940357,negative,-1.4294222751637915,negative
2021-02-23 10:41:00.000,324.9,327.0,315.1,321.85,1510369.0,"Telangana’s aiming for $100 billion life sciences exports by 2030, says Minister KT Rama Rao","Some of the companies that announced expansions and investments include Switzerland-based Ferring Pharmaceuticals, Canadian firm Jamp Pharmaceutical, Syngene, GVK Bio, Granules India, Laurus Labs and Sai Lifesciences.",neutral,neutral,-0.9387503847337504,negative,0.3711722858026565,neutral
2021-02-24 05:30:00.000,323.3,349.0,319.05,324.5,776686.0,"BRIEF-FDA Approves Granules India ANDA For Acetaminophen, Aspirin & Caffeine Tablets","BRIEF-FDA Approves Granules India ANDA For Acetaminophen, Aspirin & Caffeine Tablets",neutral,neutral,0.3711722858026565,neutral,0.2905198776758375,neutral
2021-02-24 12:22:00.000,327.0,337.85,325.65,327.95,2164307.0,Granules India gains after USFDA nod for migraine drug,"Granules India rose 1.57% to Rs 326.90 after the company said that US drug regulator has approved its Abbreviated New Drug Application (ANDA) for Acetaminophen, Aspirin and Caffeine Tablets USP, 250 mg/250 mg/65 mg (OTC).",positive,positive,0.2905198776758375,neutral,-0.0619195046439593,neutral
2021-02-24 13:44:00.000,327.0,337.85,325.65,327.95,2164307.0,"Granules India receives USFDA approval for Acetaminophen, Aspirin and Caffeine Tablets","Acetaminophen, Aspirin and Caffeine Tablets are indicated for the treatment of migraine.",positive,neutral,0.2905198776758375,neutral,-0.0619195046439593,neutral
2021-02-24 18:06:49.000,327.0,337.85,325.65,327.95,2164307.0,Granules India’s migraine drug gets USFDA nod,"Granules India Ltd’s Abbreviated New Drug Application (ANDA) for Acetaminophen, Aspirin and Caffeine tablets has been approved by the US Food and Drug Administration (USFDA).The approved ANDA is a bio",neutral,positive,0.2905198776758375,neutral,-0.0619195046439593,neutral
2021-02-24 23:04:05.000,327.0,337.85,325.65,327.95,2164307.0,U.S. FDA nod for Granules’ migraine drug,"The U.S. Food and Drug Administration has approved Granules India’s Abbreviated New Drug Application for Acetaminophen, Aspirin and Caffeine Tablets USP, 250 mg/250 mg/65 mg (OTC).The company said the",neutral,positive,0.2905198776758375,neutral,-0.0619195046439593,neutral
2021-03-02 09:04:05.000,344.5,345.5,334.5,336.0,1985321.0,"Top Buy And Sell Ideas By Sudarshan Sukhani, Mitessh Thakkar For Short Term","Mitessh Thakkar of mitesshthakkar.com recommends buying Bharat Electronics with a stop loss of Rs 142, target at Rs 155 and Granules India with a stop loss of Rs 336, target at Rs 353.",neutral,neutral,-2.467343976777939,negative,8.558758314855872,positive
2021-03-18 14:00:14.000,305.0,315.5,295.0,313.2,3196237.0,Buy Granules India: Target Of Rs 475: Sharekhan,"Sharekhan is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 475 in its research report dated March 16, 2021.",neutral,positive,2.6885245901639307,positive,-1.2071156289707787,negative
2021-03-25 12:22:30.000,310.4,311.8,300.05,302.55,2887544.0,"These 5 Stocks Gained At Least 15% In First Quarter Of Last Two Fiscal Years, Do You Own Any?",Granules India and JB Chemicals are among the stocks that were winners in Q1 of FY20 and FY19. Here are five stocks that you can consider for studying:,neutral,neutral,-2.528994845360814,negative,2.0950181458264483,positive
2021-04-20 05:01:00.000,347.0,349.0,328.1,334.25,5488096.0,Granules India (₹341.5): Buy,"Investors with a short-term perspective can buy the stock of Granules India at current levels. In March 2020, the stock took support in the band between ₹115-₹120 and began to trend upwards. Since the",neutral,positive,-3.674351585014409,negative,-0.4633089224331224,neutral
2021-04-21 18:50:05.000,334.55,341.5,330.6,333.0,3170622.0,Uma Chigurupati takes over as new Chairperson of FICCI FLO,"Along with her husband, she co-founded Granules India —which has a presence in over 70 countries and employs over 6,000 people.",neutral,neutral,-0.4633089224331224,neutral,-1.1810435042607232,negative
2021-05-06 09:31:00.000,355.9,358.3,348.3,351.8,6186570.0,"Buy Granules India, target price Rs 375: IIFL","Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 8729.30 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-1.1520089912896787,negative,-1.3031161473087882,negative
2021-05-11 05:30:00.000,364.0,370.55,350.25,358.9,16012705.0,BRIEF-Granules India March-Quarter Consol Profit Rises,BRIEF-Granules India March-Quarter Consol Profit Rises,neutral,neutral,-1.4010989010989074,negative,-5.5664335664335605,negative
2021-05-11 07:49:00.000,364.0,370.55,350.25,358.9,16012705.0,"Stocks in the news: GCPL, Linde India, HFCL, IOB, JMC Projects and IndiGo","Siemens, Aarti Industries, Linde India, KEC International, Firstsource Solution, Granules India and Neuland Labs are among companies that will announce their March quarter results today.",neutral,neutral,-1.4010989010989074,negative,-5.5664335664335605,negative
2021-05-11 08:10:30.000,364.0,370.55,350.25,358.9,16012705.0,"Stocks to Watch: PNB, InterGlobe, SBI Card, Coforge, Indian Overseas Bank","Companies that will declare their March quarter earnings include Aarti Industries, Alembic, BASF India, Firstsource Solutions, Granules India, Godrej Consumer Products, KEC International, and Linde India",neutral,neutral,-1.4010989010989074,negative,-5.5664335664335605,negative
2021-05-11 14:14:00.000,357.5,357.7,333.35,337.6,11204614.0,Granules India consolidated net profit rises 38.15% in the March 2021 quarter,Sales rise 33.24% to Rs 799.31 crore,positive,positive,-5.5664335664335605,negative,-6.131386861313868,negative
2021-05-11 19:01:00.000,357.5,357.7,333.35,337.6,11204614.0,Granules India Q4 results: Net profit rises 38% to Rs 128 cr,Consolidated revenue from operations of the company stood at Rs 799 crore for the quarter under consideration. It was Rs 600 crore for the same period a year ago.,positive,neutral,-5.5664335664335605,negative,-6.131386861313868,negative
2021-05-11 20:39:30.000,357.5,357.7,333.35,337.6,11204614.0,Granules India Q4 net up 38% at ₹128 crore,The revenue had risen 33 per cent at ₹799 crore as against ₹600 crore in the year-ago period.,positive,positive,-5.5664335664335605,negative,-6.131386861313868,negative
2021-05-11 20:44:33.000,357.5,357.7,333.35,337.6,11204614.0,"Granules India Consolidated March 2021 Net Sales At Rs 799.31 Crore, Up 33.24% Y-o-Y",,neutral,neutral,-5.5664335664335605,negative,-6.131386861313868,negative
2021-05-11 22:10:18.000,357.5,357.7,333.35,337.6,11204614.0,Granules India Q4 Net Profit Up 38% At Rs 128 Crore,The company had posted a net profit of Rs 92.33 crore for the corresponding period of the previous fiscal.,neutral,positive,-5.5664335664335605,negative,-6.131386861313868,negative
2021-05-12 10:15:00.000,357.5,357.7,333.35,337.6,11204614.0,"Buy Granules India, target price Rs 420: Motilal Oswal","Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 8913.82 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-5.5664335664335605,negative,-6.131386861313868,negative
2021-05-12 15:05:02.000,357.5,357.7,333.35,337.6,11204614.0,Dishman Carbogen Amcis Ltd leads losers in ‘A’ group,"Neuland Laboratories Ltd, Bliss GVS Pharma Ltd, Granules India Ltd and Intellect Design Arena Ltd are among the other losers in the BSE’s ‘A’ group today, 12 May 2021.",negative,negative,-5.5664335664335605,negative,-6.131386861313868,negative
2021-05-12 21:22:35.000,357.5,357.7,333.35,337.6,11204614.0,Granules India to donate 16 crore paracetamol tablets to Telangana,"Granules India Ltd has pledged to provide 16 crore paracetamol-500 mg tablets free of cost to Telangana Government to fight the covid-19 pandemic.According to a release, the Hyderabad-based company wi",neutral,positive,-5.5664335664335605,negative,-6.131386861313868,negative
2021-05-13 10:40:00.000,342.5,342.5,320.35,321.5,6565611.0,Granules India commits to donate 160 mn Paracetamol tablets to Telangana,The city-based vertically integrated pharmaceutical company will give Paracetamol-500 mg tablets free of cost to fight the Covid-19 pandemic,neutral,positive,-6.131386861313868,negative,0.3734827264238993,neutral
2021-05-16 12:49:41.000,321.3,327.0,312.8,322.5,6369831.0,"Granules India earmarks capex of Rs 1,000 crore till FY24",The compay plans to invest on a new manufacturing facility,neutral,neutral,0.3734827264238993,neutral,0.5686184109420519,neutral
2021-05-16 17:06:00.000,321.3,327.0,312.8,322.5,6369831.0,"Granules India to invest Rs 1,000 crore over 3 years till FY24 to expand operations",The Hyderabad-based firm plans to invest in a new manufacturing facility and on expanding production capacities at existing plants,positive,positive,0.3734827264238993,neutral,0.5686184109420519,neutral
2021-06-04 09:39:00.000,324.9,331.0,322.15,327.7,4133011.0,"Buy Granules India, target price Rs 335: Kotak Securities","Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 8008.56 Crore) operating in Pharmaceuticals sector.",neutral,neutral,0.8618036318867379,neutral,-0.1515610791148833,neutral
2021-06-18 11:40:50.000,318.0,320.3,308.45,311.45,3061431.0,"Despite Healthy Earnings In FY21, These 5 Stocks Are At Least 20% Away From Their 52-week High","Aarti Drugs, Tanla Platforms and Granules India are on the list",neutral,neutral,-2.05974842767296,negative,2.1266233766233804,positive
2021-06-28 09:30:00.000,313.85,319.5,312.0,316.2,1617514.0,Granules India US unit gets two observations from USFDA,The US drug regulator has completed inspection of the facility of Granules India’s US-based subsidiary on 25 June 2021 with two minor observations.,neutral,neutral,0.7487653337581538,neutral,2.3460872303574205,positive
2021-06-28 10:32:26.000,313.85,319.5,312.0,316.2,1617514.0,Granules India announces completion of USFDA inspection of its unit’s facility in Virginia,With two observations,positive,neutral,0.7487653337581538,neutral,2.3460872303574205,positive
2021-06-28 14:01:00.000,317.55,326.8,316.55,325.0,3903971.0,USFDA issues two observations after inspection of Granules India’s Chantilly facility in US,"“We will be responding to the two observations within the stipulated time period,” Granules Pharmaceuticals Executive Director Priyanka Chigurupati said.",neutral,neutral,2.3460872303574205,positive,1.9418960244648389,positive
2021-07-12 07:34:59.000,371.15,378.15,360.65,370.4,20445491.0,"Buzzing Stocks: Avenue Supermarts, Granules India, Sandu Pharma And Other Stocks In News Today",Stocks In News: Check out the companies making the biggest headlines before the opening bell.,neutral,neutral,-0.2020746328977502,neutral,-1.2335746849021094,negative
2021-07-12 10:59:40.000,371.15,378.15,360.65,370.4,20445491.0,Granules India Shares Jumps 2% After Company Denies Reports Of Being Sold To PE Investors,The company has slammed as “utterly false and malicious” messages floating around on social media about the firm being sold to some PE investors.,neutral,negative,-0.2020746328977502,neutral,-1.2335746849021094,negative
2021-07-12 17:30:00.000,372.9,374.1,367.0,368.3,4419884.0,"‘Not selling company to PE investors; reports false, malicious’: Granules India clarifies",The pharma company said in a BSE filing that the management remains committed to the growth of the company,neutral,positive,-1.2335746849021094,negative,1.2228260869565215,positive
2021-07-13 11:55:53.000,372.9,374.1,367.0,368.3,4419884.0,Granules India Q1 PAT Seen Up 54.7% YoY To Rs 99.2 Cr: KRChoksey,"Net Sales are expected to decrease by 9.5 percent Y-o-Y (down 22.4 percent Q-o-Q) to Rs 666 crore, according to KRChoksey.",neutral,negative,-1.2335746849021094,negative,1.2228260869565215,positive
2021-07-13 12:34:09.000,368.0,374.05,368.0,372.5,3062523.0,Granules India concludes its Covid-19 vaccine drive for its workforce,"Since the pandemic started, Granules recorded over 625 positive cases at its units",neutral,positive,1.2228260869565215,positive,-0.6836461126005392,neutral
2021-07-13 14:17:40.000,368.0,374.05,368.0,372.5,3062523.0,Granules India Concludes COVID-19 Vaccine Drive For All Its Employees In India,"The on-premises vaccination drive was conducted in association with government authorised hospitals and the vaccines were administered to over 4,500 employees as per the government approved protocols, Granules India said in a statement.",neutral,neutral,1.2228260869565215,positive,-0.6836461126005392,neutral
2021-07-13 16:21:00.000,368.0,374.05,368.0,372.5,3062523.0,Bulk Deals: BNP Paribas buys shares in Granules; IDBI Bank sells stake in Zicom Electronic,BNP Paribas Arbitrage acquired additional 12.52 lakh equity shares in Granules India at Rs370.55 per share on the NSE.,neutral,neutral,1.2228260869565215,positive,-0.6836461126005392,neutral
2021-07-21 13:56:00.000,374.7,385.0,372.15,383.6,5605750.0,Granules India subsidiary clears USFDA audit,The drug maker on Wednesday announced that its US-based subsidiary cleared a pre-approval inspection (PAI) audit by the US drug regulator.,neutral,positive,2.375233520149462,positive,-1.581540057039141,negative
2021-07-21 16:02:40.000,374.7,385.0,372.15,383.6,5605750.0,Granules subsidiary clears USFDA pre-approval audit,"Drug firm Granules India on Wednesday said its US-based facility has cleared an audit by the US health regulator.Granules Pharmaceuticals, Inc (GPI), a Virginia-based wholly-owned subsidiary of the company, had undergone a pre-approval inspection (PAI) audit by the US Food and Drug Adminis…",neutral,neutral,2.375233520149462,positive,-1.581540057039141,negative
2021-07-21 18:31:21.000,374.7,385.0,372.15,383.6,5605750.0,USFDA closes observations on Granules India’s arm,"Earlier, it had issued two minor observations during the audit.",neutral,neutral,2.375233520149462,positive,-1.581540057039141,negative
2021-07-27 18:02:00.000,370.0,383.9,358.25,371.0,14826539.0,Granules India standalone net profit declines 28.12% in the June 2021 quarter,Sales decline 1.45% to Rs 732.12 crore,negative,negative,0.2702702702702703,neutral,-1.0430596416153992,negative
2021-07-27 19:10:21.000,370.0,383.9,358.25,371.0,14826539.0,"Granules India Net Profit Rises 8% In Q1 FY22, Margins Down","Revenue from operations rose 16 percent YoY to Rs 850 crore in Q1FY22, compared to Rs 736 crore during corresponding quarter of previous year.",neutral,positive,0.2702702702702703,neutral,-1.0430596416153992,negative
2021-07-27 22:55:45.000,370.0,383.9,358.25,371.0,14826539.0,"Granules posts higher net, income in Q1, declares interim","Drugmaker Granules India has posted ₹120 crore in consolidated net profit for the quarter ended June, an 8% increase compared with the ₹111 crore of the corresponding period of the previous fiscal.Inc",positive,positive,0.2702702702702703,neutral,-1.0430596416153992,negative
2021-07-27 23:08:00.000,370.0,383.9,358.25,371.0,14826539.0,Drug firm Granules India Q1 consolidated net profit up 8% to Rs 120 cr,"Drug firm Granules India on Tuesday reported an 8 per cent rise in its consolidated net profit to Rs 120 crore for the quarter ended June 30, 2021.",positive,positive,0.2702702702702703,neutral,-1.0430596416153992,negative
2021-07-28 00:01:00.000,370.0,383.9,358.25,371.0,14826539.0,Granules India Q1 results: Net profit up 8% to Rs 120 crore,"Consolidated revenue from operations of the company stood at Rs 850 crore for the quarter under consideration. It was Rs 736 crore for the same period a year ago, it added.",positive,neutral,0.2702702702702703,neutral,-1.0430596416153992,negative
2021-07-28 07:47:00.000,370.0,383.9,358.25,371.0,14826539.0,Granules India consolidated net profit rises 7.85% in the June 2021 quarter,Sales rise 15.53% to Rs 849.85 crore,positive,positive,0.2702702702702703,neutral,-1.0430596416153992,negative
2021-07-28 10:40:00.000,370.0,383.9,358.25,371.0,14826539.0,Granules spurts after Q1 PAT rises 8% YoY to Rs 120 cr,Granules India rose 1.41% to Rs 369.85 after the drug company posted a 7.9% rise in consolidated net profit to Rs 120.2 crore on a 15.5% increase in net sales to Rs 849 crore in Q1 FY22 over Q1 FY21.,positive,positive,0.2702702702702703,neutral,-1.0430596416153992,negative
2021-07-28 17:30:00.000,373.9,376.4,369.3,370.0,2532753.0,"Stocks in news: Tata Motors, IndusInd Bank, Maruti Suzuki, Granules India and more","Stocks in news: Granules India, Tata Motors, Dalmia Bharat, Maruti Suzuki, Canara Bank and more",neutral,neutral,-1.0430596416153992,negative,1.6042780748663104,positive
2021-07-29 15:51:17.000,374.0,384.7,372.0,380.0,3816147.0,Granules India Q1 Review - On Track To Build Product Pipeline As Well As Capacity: Motilal Oswal,Granules India Q1 Review - On Track To Build Product Pipeline As Well As Capacity: Motilal Oswal,neutral,neutral,1.6042780748663104,positive,0.6554798112218144,neutral
2021-08-02 11:31:06.000,381.4,390.95,378.3,383.9,4851098.0,Volumes soar at Granules India Ltd counter,"Granules India Ltd clocked volume of 25.32 lakh shares by 10:50 IST on BSE, a 8.3 times surge over two-week average daily volume of 3.05 lakh shares",neutral,positive,0.6554798112218144,neutral,-1.0772225827384756,negative
2021-08-04 14:17:14.000,387.0,396.5,382.35,387.0,4147074.0,Buy Granules India; Target Of Rs 459: KR Choksey,"KR Choksey is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 459 in its research report dated July 28, 2021.",neutral,positive,0.0,neutral,-2.256608639587363,negative
2021-08-04 17:30:22.000,387.0,396.5,382.35,387.0,4147074.0,Buy Granules India; Target Of Rs 430: ICICI Direct,"ICICI Direct is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 430 in its research report dated July 29, 2021.",neutral,positive,0.0,neutral,-2.256608639587363,negative
2021-08-30 10:30:00.000,333.0,337.55,330.1,331.05,2041226.0,Health Canada approves Granules India’s Acetaminophen extended-release tablets,"The product manufactured by Granules is bioequivalent to the reference listed drug, Tylenol Extended-Release 650 Tablets.",neutral,neutral,-0.5855855855855822,neutral,-0.8091099790230711,neutral
2021-08-30 12:03:00.000,333.7,334.35,329.5,331.0,1431851.0,Granules India rises after Health Canada approval for acetaminophen tablets,"Granules India rose 1.28% to Rs 334.75 after the drug maker announced receiving marketing approval from Health Canada for acetaminophen extended-release tablets OTC, 650 mg for the treatment of arthritis pain.",positive,positive,-0.8091099790230711,neutral,4.135224871717473,positive
2021-08-30 13:51:06.000,333.7,334.35,329.5,331.0,1431851.0,Granules India Gets Health Canada Nod To Market Arthritis Tablets,"The company has received approval from Health Canada for Acetaminophen extended-release tablets OTC, 650 mg, Granules India said in a regulatory filing.",neutral,positive,-0.8091099790230711,neutral,4.135224871717473,positive
2021-08-30 14:24:00.000,333.7,334.35,329.5,331.0,1431851.0,Granules India gets Health Canada nod to market arthritis tablets,"The drug will be manufactured at the company’s manufacturing facility located in Gagillapur, Hyderabad, the filing said.",neutral,neutral,-0.8091099790230711,neutral,4.135224871717473,positive
2021-08-30 14:29:46.000,333.7,334.35,329.5,331.0,1431851.0,Granules India gets Health Canada nod to market arthritis tablets; shares up,Granules India gets Health Canada nod to market arthritis tablets; shares up,positive,positive,-0.8091099790230711,neutral,4.135224871717473,positive
2021-08-30 17:06:13.000,333.7,334.35,329.5,331.0,1431851.0,Granules India gets Health Canada’s approval for its Arthritis pain reliever,Granules now have a total of two ANDS (abbreviated new drug submissions) approvals from Health Canada.,positive,neutral,-0.8091099790230711,neutral,4.135224871717473,positive
2021-09-02 18:34:20.000,350.0,352.85,338.85,340.0,4140437.0,2-DG: Granules India Gets Licence from DRDO to Manufacture and Market Covid Drug,"Drug firm Granules India on Thursday said it has received licence from Defence Research & Development Organisation (DRDO) to manufacture and market COVID-19 treatment drug, 2- Deoxy-D-Glucose (2-DG).",neutral,positive,-2.857142857142857,negative,-2.571219868517169,negative
2021-09-02 18:36:42.000,350.0,352.85,338.85,340.0,4140437.0,"Granules India gets licence from DRDO to manufacture, market 2-DG Covid drug","‘Granules is working closely with DRDO team to launch the product in India at the earliest,’ the drug firm said",neutral,positive,-2.857142857142857,negative,-2.571219868517169,negative
2021-09-02 18:48:00.000,350.0,352.85,338.85,340.0,4140437.0,Granules India gets licence from DRDO to manufacture and market COVID-19 drug 2-DG,"Developed by DRDO, 2-DG has been granted permission by Drug Controller General of India (DCGI) for emergency use as adjunct therapy in moderate to severe COVID-19 patients, Granules India said in a filing to BSE.",neutral,positive,-2.857142857142857,negative,-2.571219868517169,negative
2021-09-02 19:36:10.000,350.0,352.85,338.85,340.0,4140437.0,Granules India Gets Licence From DRDO To Manufacture And Market COVID-19 Drug,"Developed by DRDO, 2-DG has been granted permission by Drug Controller General of India (DCGI) for emergency use as adjunct therapy in moderate to severe COVID-19 patients, Granules India said in a filing to BSE.",neutral,positive,-2.857142857142857,negative,-2.571219868517169,negative
2021-09-02 23:14:16.000,350.0,352.85,338.85,340.0,4140437.0,Granules gets DRDO licence for 2-DG,"Granules India has received licence from the Defence Research &amp; Development Organisation (DRDO) to manufacture and market 2-Deoxy-D-Glucose (2-DG). Developed by DRDO, 2-DG has been approved b",neutral,positive,-2.857142857142857,negative,-2.571219868517169,negative
2021-09-03 07:36:37.000,350.0,352.85,338.85,340.0,4140437.0,"Stocks To Watch: Reliance Industries, Granules India, IRB Infrastructure, RailTel Corp, J&K Bank",Here are the stocks to watch in trade today...,neutral,neutral,-2.857142857142857,negative,-2.571219868517169,negative
2021-09-03 08:32:00.000,350.0,352.85,338.85,340.0,4140437.0,"RIL, Granules India, RailTel Corporation in focus","Reliance Industries’ (RIL) subsidiary Reliance Retail Ventures (RRVL) has now taken sole control of Just Dial. On July 20, 2021, RRVL acquired 1.31 crore equity shares of Just Dial at a price of Rs.1,020/- per equity share from Mr. VSS Mani. On",neutral,neutral,-2.857142857142857,negative,-2.571219868517169,negative
2021-09-03 09:23:00.000,350.0,352.85,338.85,340.0,4140437.0,"Granules India gains after DRDO license to manufacture, market 2-DG COVID drug","Granules India rose 1.70% after the company said that it has received licence from Defence Research & Development Organisation (DRDO), Ministry of Defence, Government of India, to manufacture and market of 2- Deoxy-D-Glucose (2-DG).",positive,positive,-2.857142857142857,negative,-2.571219868517169,negative
2021-09-03 15:11:00.000,350.0,352.85,338.85,340.0,4140437.0,Granules India receives license from DRDO to manufacture and market 2-DG,2- Deoxy-D-Glucose has been granted permission by DCGI for emergency use of this drug as an adjunct therapy in moderate to severe Covid 19 patients.,positive,positive,-2.857142857142857,negative,-2.571219868517169,negative
2021-09-12 13:25:00.000,327.85,327.85,321.65,322.9,2007677.0,"Drug firms Granules India, Jubilant Cadista recall products in US market","Jubilant Cadista is a fully-owned subsidiary of Cadista Holdings Inc, which is a part of the Noida-based Jubilant Life Sciences Company.",neutral,neutral,-1.5098368156169115,negative,3.4461538461538423,positive
2021-09-12 16:52:00.000,327.85,327.85,321.65,322.9,2007677.0,"Drug makers Granules India, Jubilant Cadista recall products in US market","Salisbury-based Jubilant Cadista Pharmaceuticals Inc is a fully-owned subsidiary of Cadista Holdings Inc, which is a part of Noida-based Jubilant Life Sciences.",negative,neutral,-1.5098368156169115,negative,3.4461538461538423,positive
2021-09-13 09:42:00.000,327.85,327.85,321.65,322.9,2007677.0,Granules India issues voluntary recall of one batch of Naproxen Sodium 220mg tablets; Stock ends lower,One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled due to a minor CGMP deviation.,negative,neutral,-1.5098368156169115,negative,3.4461538461538423,positive
2021-09-13 12:18:00.000,325.0,337.4,324.05,336.2,2721532.0,Granules India declines on voluntary recalling batch of naproxen sodium tablets,Granules India slipped 1.19% to Rs 324.35 after the company said that it is voluntarily recalling one batch of naproxen sodium 220mg tablets at a retail level due to a minor CGMP deviation.,negative,negative,3.4461538461538423,positive,-0.7883385393425486,neutral
2021-09-13 14:32:48.000,325.0,337.4,324.05,336.2,2721532.0,Granules India voluntarily recalls one batch of Naproxen Sodium tablets,Move was on account of minor CGMP deviation,neutral,neutral,3.4461538461538423,positive,-0.7883385393425486,neutral
2021-10-01 08:15:00.000,319.0,328.3,318.1,327.35,1858405.0,Granules India allots over 3.30 lakh equity shares under ESOS; Stock gains,"The current market cap of the company is Rs7,935.50cr.",neutral,neutral,2.6175548589341764,positive,-0.3952569169960336,neutral
2021-10-07 15:37:00.000,329.8,333.6,324.95,326.5,1382346.0,Jyothi Prasad resigns as Independent Director at Granules India,The company confirms in a filing that there are no other material reasons for her resignation.,neutral,neutral,-1.000606428138269,negative,0.3058103975535168,neutral
2021-10-18 15:00:00.000,325.8,327.2,317.65,318.9,1295343.0,Granules India receives USFDA approval for Dofetilide capsules,"Granules India announced that the USFDA has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc. for dofetilide capsules.",positive,positive,-2.117863720073675,negative,-0.78125,neutral
2021-11-12 23:44:40.000,318.1,319.05,308.25,312.8,1344439.0,Granules India warns on guidance after Q2 net slumps,"Business during the quarter was impacted due to difficulties in procuring raw materials, mainly from China",neutral,negative,-1.6661427224143388,negative,1.342281879194631,positive
2021-11-15 09:59:19.000,298.0,308.5,280.5,302.0,9706848.0,Granules India Q2 Review - Elevated key Starting Materials Prices Impact Earnings: Motilal Oswal,Granules India Q2 Review - Elevated key Starting Materials Prices Impact Earnings: Motilal Oswal,neutral,neutral,1.342281879194631,positive,-2.2222222222222223,negative
2021-11-15 14:32:00.000,303.75,307.4,296.0,297.0,2537204.0,"Granules India, IOL Chemicals hit 52-week lows on weak Q2 results","IOL Chemicals slipped 10% to Rs 487, while Granules was down 8% to 285.80 on the BSE in intra-day trade",negative,negative,-2.2222222222222223,negative,1.4285714285714286,positive
2021-11-18 11:12:00.000,304.0,306.9,299.05,304.2,1983075.0,"Accumulate Granules India, target price Rs 349: Geojit","Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 7510.74 Crore) operating in Pharmaceuticals sector.",neutral,neutral,0.0657894736842067,neutral,-0.605564648117847,neutral
2021-11-18 18:21:04.000,304.0,306.9,299.05,304.2,1983075.0,Granules India Q2 Review - Q2 Performance Below Expectations: Centrum Broking,Granules India Q2 Review - Q2 Performance Below Expectations: Centrum Broking,neutral,neutral,0.0657894736842067,neutral,-0.605564648117847,neutral
2021-12-13 22:25:33.000,340.5,346.8,336.05,339.55,1720835.0,Granules appoints former CFO of Dr. Reddy’s as additional director,"Drugmaker Granules India has appointed Saumen Chakraborty, a former top level executive of Dr. Reddy’s Laboratories, as an additional director.The Board of Directors has appointed Saumen Chakraborty a",neutral,neutral,-0.2790014684287779,neutral,-0.6413994169096177,neutral
2021-12-21 16:54:00.000,310.0,323.4,308.2,321.1,1158912.0,Ind Ra affirms Granules India long-term issuer rating at ‘AA-/ Stable’,The agency continues to take a consolidated view of GIL and its wholly owned subsidiaries.,positive,neutral,3.58064516129033,positive,2.592592592592585,positive
2021-12-23 10:17:00.000,324.0,335.8,318.2,332.4,2352299.0,"Ind-Ra assigns Granules India’s additional bank facility ‘AA-’ with stable outlook, affirms other ratings",Ind-Ra assigned,positive,neutral,2.592592592592585,positive,-2.031063321385905,negative
2021-12-23 13:58:00.000,334.8,336.9,325.25,328.0,1192560.0,Granules India appoints Sucharita Rao Palepu as independent director,"Palepu brings with her a rich and varied experience of two decades in information technology and financial services. She is currently a strategic advisor specializing in organization and HR transformation initiatives, the company said in a statement.",neutral,neutral,-2.031063321385905,negative,3.4158190374981023,positive
2021-12-28 09:37:00.000,340.0,343.9,333.7,336.15,2095076.0,Granules India bags USFDA nod for Prazosin Hydrochloride capsules,"The United States Food & Drug Administration has approved the Abbreviated New Drug Application filed by Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of Granules India, for Prazosin Hydrochloride capsules, USP 1mg, 2mg & 5mg.",neutral,positive,-1.1323529411764772,negative,1.9910179640718493,positive
2021-12-28 10:16:27.000,340.0,343.9,333.7,336.15,2095076.0,Granules India receives USFDA approval for Prazosin Hydrochloride Capsules,Powered by Capital Market - Live News,positive,neutral,-1.1323529411764772,negative,1.9910179640718493,positive
2021-12-28 12:16:00.000,334.0,343.15,334.0,340.65,1511987.0,Granules India gets USFDA nod for generic Prazosin Hydrochloride capsules,"The US Food & Drug Administration (USFDA) granted approval to the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI) -- a wholly owned foreign subsidiary of the company -- for Prazosin Hydrochloride capsules, of strengths 1mg, 2mg and 5mg, Granules India Limited sai…",neutral,positive,1.9910179640718493,positive,-0.8919432665594418,neutral
2021-12-28 12:40:30.000,334.0,343.15,334.0,340.65,1511987.0,Granules India Gets USFDA Nod For Generic Prazosin Hydrochloride Capsules,"The US Food & Drug Administration (USFDA) granted approval to the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI) — a wholly owned foreign subsidiary of the company — for Prazosin Hydrochloride capsules, of strengths 1mg, 2mg and 5mg, Granules India Limited said …",neutral,positive,1.9910179640718493,positive,-0.8919432665594418,neutral
2021-12-28 18:04:00.000,334.0,343.15,334.0,340.65,1511987.0,Granules India gets USFDA approval for Prazosin Hydrochloride Capsules,The product would be available for the US market shortly.,positive,neutral,1.9910179640718493,positive,-0.8919432665594418,neutral
2021-12-30 10:10:00.000,341.95,342.05,334.6,338.9,1248433.0,Granules India gets ANDA approval for Amphetamine mixed salts tablets,Granules now has a total of 47 ANDA approvals from the US Food & Drug Administration (US FDA) (45 final approvals and 2 tentative approvals).,positive,neutral,-0.8919432665594418,neutral,-0.266745702430343,neutral
2021-12-30 10:20:00.000,341.95,342.05,334.6,338.9,1248433.0,Granules India receives USFDA approval for Amphetamine Mixed Salts IR Tablets,Granules now have a total of 47 ANDA approvals from the US FDA (45 Final approvals and 2 tentative approvals).,positive,neutral,-0.8919432665594418,neutral,-0.266745702430343,neutral
2021-12-30 13:25:10.000,337.4,344.8,332.05,336.5,1182592.0,Granules India gets USFDA nod for its generic Amphetamine mixed salts,"It is bioequivalent to the reference-listed drug product (RLD), Adderall of Teva Women’s Health Inc",neutral,neutral,-0.266745702430343,neutral,-0.356930398572275,neutral
2021-12-30 17:15:00.000,337.4,344.8,332.05,336.5,1182592.0,Granules India bags USFDA approval for Amphetamine Mixed Salts,Granules now have a total of 47 ANDA approvals from the US FDA (45 Final approvals and 2 tentative approvals).,positive,neutral,-0.266745702430343,neutral,-0.356930398572275,neutral
2022-01-04 14:01:00.000,325.8,334.9,323.25,327.3,1263536.0,"Pharma company Granules India names KVS Ram Rao as Joint MD, CEO",Rao has over two decades of experience in pharmaceutical and chemical industries.,neutral,neutral,0.4604051565377531,neutral,-0.6574923547400542,neutral
2022-01-04 14:45:44.000,325.8,334.9,323.25,327.3,1263536.0,Granules India appoints KVS Ram Rao as JMD and CEO,Rao has over two decades of experience in pharmaceuticals and chemical industries,neutral,neutral,0.4604051565377531,neutral,-0.6574923547400542,neutral
2022-01-05 06:35:00.000,325.8,334.9,323.25,327.3,1263536.0,"Nifty Pharma stocks trim early gains to trade flat; Alembic Pharma drags while Laurus Labs, Gland Pharma outperform","Cadila and Divis Lab were also under selling pressure. Granules India, Strides Pharma, and IPCA Labs were bullish.",negative,positive,0.4604051565377531,neutral,-0.6574923547400542,neutral
2022-01-12 08:45:00.000,338.9,340.9,331.0,333.5,1888306.0,"Buy Granules India, target price Rs 360: Yes Securities","Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 8328.03 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-1.593390380643251,negative,2.4663677130044843,positive
2022-01-17 15:31:11.000,332.0,335.0,322.0,323.2,2608918.0,Bhansali Engineering Polymers Ltd leads losers in ‘A’ group,"Hikal Ltd, Granules India Ltd, Hinduja Global Solutions Ltd and HCL Technologies Ltd are among the other losers in the BSE’s ‘A’ group today, 17 January 2022.",negative,negative,-2.6506024096385574,negative,-1.8704591126913004,negative
2022-01-18 07:57:15.000,332.0,335.0,322.0,323.2,2608918.0,Granules India added to the list of stocks under F&O ban on NSE today,"Vodafone Idea, SAIL, Indiabulls Housing Finance, Escorts continue to be among stocks list of F&O ban by the NSE",neutral,neutral,-2.6506024096385574,negative,-1.8704591126913004,negative
2022-01-20 08:24:21.000,317.3,326.35,314.4,322.5,1856593.0,Ipca Labs To Granules India: Bulk Drug Makers’ Q3 Margin Under Pressure,Raw material inflation to be a drag on API makers’ Q3 margins.,neutral,negative,1.6388276079420072,positive,-0.8882655446470383,neutral
2022-01-31 08:49:00.000,303.5,307.75,302.75,303.2,977933.0,Granules India announces three observations from USFDA at its US-based facility,"The wholly-owned foreign subsidiary of Granules India, Granules Pharmaceuticals, Inc. (GPI) in Chantilly, Virginia (US) had undergone a pre-approval inspection by the US Food and Drug Administration (USFDA) from 24 to 28 January 2022.",neutral,neutral,-0.0988467874794106,neutral,2.3114754098360693,positive
2022-01-31 12:32:00.000,305.0,314.0,304.0,312.05,935372.0,USFDA issues 3 minor observations to Granules India arm in pre-approval inspection,"Commenting on the audit, GPI Executive Director Priyanka Chigurupati said, “We are glad to have completed yet another audit with minor observations that we will respond to within the stipulated time period”.",neutral,positive,2.3114754098360693,positive,2.8913738019169366,positive
2022-01-31 13:42:07.000,305.0,314.0,304.0,312.05,935372.0,USFDA Issues 3 Minor Observations To Granules India Arm In Pre-approval Inspection,"Granules Pharmaceuticals located in Chantilly, Virginia, US, had undergone a PAI by the US Food and Drug Administration (USFDA) from January 24-28, 2022, the company said in a statement.",neutral,neutral,2.3114754098360693,positive,2.8913738019169366,positive
2022-02-03 13:05:46.000,324.5,325.45,316.5,320.3,1017930.0,Granules India Ltd up for fifth session,"Granules India Ltd is quoting at Rs 324.55, up 1% on the day as on 12:49 IST on the NSE. The stock is down 6.63% in last one year as compared to a 18.7% spurt in NIFTY and a 6.78% spurt in the Nifty Pharma.",neutral,positive,-1.294298921417562,negative,-2.7208756841282216,negative
2022-02-03 16:10:00.000,324.5,325.45,316.5,320.3,1017930.0,Granules India gets USFDA nod for generic antidepressant drug,"“We are pleased to receive approval of Bupropion Hydrochloride (XL) tablet product within first review cycle of 10 months from filing date. This product will be a valuable addition to our growing modified release product portfolio in the US market,” GPI Executive Director Priyanka Chigurupati stated…",neutral,positive,-1.294298921417562,negative,-2.7208756841282216,negative
2022-02-03 16:48:00.000,324.5,325.45,316.5,320.3,1017930.0,Granules India gets USFDA approval for generic antidepressant drug,Bupropion Hydrochloride is used as an antidepressant medication to treat major depressive disorder and seasonal affective disorder,positive,neutral,-1.294298921417562,negative,-2.7208756841282216,negative
2022-02-03 16:50:45.000,324.5,325.45,316.5,320.3,1017930.0,Granules India Gets USFDA Nod For Generic Antidepressant Drug,"Granules Pharmaceuticals, Inc (GPI), a wholly-owned subsidiary of the company, has received approval from the US Food & Drug Administration (USFDA) to market the product in strengths of 150 mg and 300 mg, the Hyderabad-based drug firm said in a statement.",neutral,positive,-1.294298921417562,negative,-2.7208756841282216,negative
2022-02-08 10:54:00.000,311.85,316.0,301.5,308.25,2537457.0,Granules India reports Q3 PAT down by 31.3% YoY,"Its EBITDA for Q3 FY’22 was reported at Rs 173.70 crore against Rs 211.60 crore for Q3 FY’21, decreasing 21.82% YoY.",negative,negative,-1.1544011544011616,negative,0.3215951117543013,neutral
2022-02-08 23:34:26.000,310.95,315.85,306.0,311.95,737848.0,Granules net falls 31% on higher freight cost,"Drugmaker Granules India reported consolidated net profit declined 31% to ₹101 crore for the December quarter on the back of increase in freight cost and lower gross margins. The lower net profit, com",positive,negative,0.3215951117543013,neutral,-0.4149377593361032,neutral
2022-02-09 11:15:54.000,310.95,315.85,306.0,311.95,737848.0,"Granules India Consolidated December 2021 Net Sales at Rs 996.77 crore, up 18.03% Y-o-Y",,positive,neutral,0.3215951117543013,neutral,-0.4149377593361032,neutral
2022-02-09 18:49:00.000,313.3,315.35,310.45,312.0,544627.0,"Centrum Broking gives ‘buy’ call for Vijaya Diagnostic, Granules India",Brokerage house Centrum Broking has given a ‘buy’ call for Vijaya Diagnostic Centre and Granules India stocks,neutral,positive,-0.4149377593361032,neutral,-1.4516129032258065,negative
2022-02-11 20:35:39.000,310.0,311.8,305.0,305.5,736380.0,Buy Granules India; target of Rs 360: ICICI Direct,"ICICI Direct is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 360 in its research report dated February 10, 2021.",neutral,positive,-1.4516129032258065,negative,0.0,neutral
2022-02-22 14:04:52.000,291.1,294.25,284.0,284.85,706776.0,Granules India Ltd tumbles 4.5%,"Granules India Ltd is quoting at Rs 284.2, down 4.5% on the day as on 13:24 IST on the NSE. The stock tumbled 11.63% in last one year as compared to a 15.16% rally in NIFTY and a 6.28% spurt in the Nifty Pharma index.",negative,negative,-2.1470285125386463,negative,-4.375,negative
2022-03-11 17:30:00.000,291.3,309.5,291.2,309.0,2734866.0,"Nifty Pharma surges over 1.5% amid volatile trade; Sun Pharma, Dr Reddy’s, Cipla lead gains","Laurus Labs and Granules India rose 4.27% each to lif the performance of the Index. Cipla rose 3.33% at Rs1,019.90 per piece. Abbot India and Strides Pharma were the top losers in the sector.",positive,positive,6.076210092687946,positive,-2.5628626692456447,negative
2022-03-15 11:37:07.000,305.5,313.8,301.0,301.3,1859395.0,Granules India edges higher after subsidiary clears US FDA audit,"Granules Pharmaceuticals, Inc, a wholly-owned foreign subsidiary located in Chantilly, Virginia, US received an Establishment Inspection Report from the US FDA",positive,neutral,-1.3747954173486052,negative,-0.326797385620915,neutral
2022-03-21 07:13:00.000,310.0,319.9,307.0,313.0,2500887.0,"Stocks in the news: RIL, Granules India, HDFC, SBI, Dodla Dairy and NMDC","Reliance Retail Ventures announced the acquisition of a majority 89 per cent equity stake in Clovia, an industry leader in the bridge-to-premium intimate wear category, with an investment of Rs 950 crore.",neutral,positive,0.967741935483871,positive,-0.7171314741035857,neutral
2022-03-21 09:09:53.000,310.0,319.9,307.0,313.0,2500887.0,"Stocks in Focus on March 21: RIL, HDFC, Granules India & More By Investing.com","Stocks in Focus on March 21: RIL, HDFC, Granules India & More",neutral,neutral,0.967741935483871,positive,-0.7171314741035857,neutral
2022-03-21 15:23:00.000,313.75,315.5,308.5,311.5,1091478.0,Granules India spurts on receiving license from MPP to market Nirmatrelvir; Ritonavir,"Granules India advanced 2.98% to Rs 314.50 after the company received a license from Medicines Patent Pool (MPP) to manufacture and market generic versions of Pfizer’s oral treatment Nirmatrelvir, co-packaged with Ritonavir for treatment of",positive,positive,-0.7171314741035857,neutral,-0.4645202626942139,neutral
2022-03-21 17:30:00.000,313.75,315.5,308.5,311.5,1091478.0,"Stocks in news: SBI, Reliance Industries, HDFC, KEI Industries and more","Stocks in news: Granules India, Torrent Pharma, State Bank of India, RIL, HDFC, Dhanlaxmi Bank, KEI Industries and more",neutral,neutral,-0.7171314741035857,neutral,-0.4645202626942139,neutral
2022-03-23 17:30:00.000,310.1,322.0,307.7,315.0,2915828.0,"Nifty Pharma stocks continue to rally; Dr. Reddy’s, Strides Pharma emerge top gainers","Alkem Lab, Pfizer, and Divis Lab were also among the top gainers. Cipla, Granules India, and Lupin were trading in the red.",positive,positive,1.5801354401805794,positive,0.9523809523809524,positive
2022-05-18 21:57:37.000,253.3,260.0,243.0,246.4,1696968.0,Granules India’s Q4 net down 13 per cent at ₹111 crore,Board recommends a final dividend of 75 paise per equity share of ₹1 each,negative,neutral,-2.724042637189106,negative,7.894736842105267,positive
2022-05-19 09:00:56.000,253.3,260.0,243.0,246.4,1696968.0,"Granules India Consolidated March 2022 Net Sales at Rs 1,029.97 crore, up 28.86% Y-o-Y",,positive,neutral,-2.724042637189106,negative,7.894736842105267,positive
2022-05-20 10:43:24.000,250.8,272.9,247.0,270.6,5390182.0,"Granules India Q4 Review - Ebitda Margins Inched Up, Amid Rising Input Costs: KRChoksey","Granules India Q4 Review - Ebitda Margins Inched Up, Amid Rising Input Costs: KRChoksey",neutral,neutral,7.894736842105267,positive,1.7216117216117175,positive
2022-05-20 20:09:57.000,250.8,272.9,247.0,270.6,5390182.0,Buy Granules India; target of Rs 345: ICICI Direct,"ICICI Direct is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 345 in its research report dated May 19, 2022.",neutral,positive,7.894736842105267,positive,1.7216117216117175,positive
2022-05-24 13:31:34.000,281.4,281.9,252.45,254.1,1542417.0,Granules India Ltd up for third straight session,"Granules India Ltd is quoting at Rs 283.25, up 1.05% on the day as on 12:49 IST on the NSE. The stock is down 11.32% in last one year as compared to a 6.66% spurt in NIFTY and a 9.54% spurt in the Nifty Pharma index.",positive,positive,-9.701492537313428,negative,0.836738665109957,neutral
2022-05-26 08:49:34.000,256.95,259.95,250.4,259.1,1048677.0,Granules India - Scaling Up In Size: Dolat Capital Initiates Coverage,Granules India - Scaling Up In Size: Dolat Capital Initiates Coverage,neutral,neutral,0.836738665109957,neutral,1.2362114872575125,positive
2022-05-31 17:30:00.000,269.65,273.45,265.7,270.25,694573.0,"Taking Stock | Markets end lower on another volatile day; metals hit, banks shine","More than 100 stocks, including SAIL India, Rallies India, Dabur India, Nestle India and Granules India, touched their 52-week low on the BSE",negative,negative,0.2225106619692278,neutral,0.6111111111111027,neutral
2022-06-02 17:30:00.000,273.5,278.5,268.2,268.2,644193.0,"Taking Stock | Sell-off continues for fourth day; Nifty ends below 16,200, Sensex falls 276 pts","Over 250 stocks, including Wipro, Torrent Pharmaceuticals, Jindal Saw, Hindustan Zinc, Granules India, Aurobindo Pharma, Ashoka Buildcon, IDFC First Bank, and KEC International, touched their 52-week low on the BSE.",neutral,negative,-1.937842778793423,negative,0.8543833580980726,neutral
2022-06-29 19:52:16.000,277.0,279.35,270.6,273.3,1355506.0,"Granules India Ltd soars 0.29%, rises for fifth straight session","Granules India Ltd is quoting at Rs 276.05, up 0.29% on the day as on 12:44 IST on the NSE. The stock is down 17% in last one year as compared to a 0.47% gain in NIFTY and a 15.37% gain in the Nifty Metal.",positive,positive,-1.335740072202162,negative,2.241822859242913,positive
2022-07-06 10:45:31.000,277.0,277.0,273.2,276.0,850601.0,Granules India to double its R&D efforts to develop innovative products,"In the last financial year, the company had spent ₹143 crore on R&D and set up its state-of-the-art centre, where about 150 scientists are working.",positive,neutral,-0.3610108303249097,neutral,-0.0540832882639387,neutral
2022-07-11 13:17:39.000,294.75,298.65,292.75,294.95,1230571.0,Granules India Ltd rises for third consecutive session,"Granules India Ltd is quoting at Rs 296.2, up 6.07% on the day as on 12:49 IST on the NSE. The stock is down 20.6% in last one year as compared to a 2.88% jump in NIFTY and a 13.02% jump in the Nifty Metal index.",positive,positive,0.0678541136556365,neutral,1.9641043007111447,positive
2022-08-10 12:38:33.000,304.0,308.55,295.35,306.0,2144922.0,Granules India’s Q1 net up 6 per cent at Rs 128 crore,Board approves share buyback for a maximum amount of Rs 250 cr,neutral,neutral,0.6578947368421052,neutral,1.0947712418300728,positive
2022-08-11 12:01:15.000,306.0,313.0,305.0,309.35,1836643.0,Granules India Q1 Review - Ease Of Cost Factors To Drive A Better Outlook: Motilal Oswal,Granules India Q1 Review - Ease Of Cost Factors To Drive A Better Outlook: Motilal Oswal,neutral,neutral,1.0947712418300728,positive,1.527331189710611,positive
2022-08-26 11:50:09.000,308.9,312.9,307.25,308.0,1081629.0,Granules India rises as Virginia facility gets VAI classification,"Granules India rose 1.47% to Rs 311 after the USFDA classified Granules Pharmaceuticals, Inc’s Virginia facility as Voluntary Action Indicated (VAI).",neutral,positive,-0.2913564260278334,neutral,-0.4776021080369056,neutral
2022-08-26 12:38:08.000,308.9,312.9,307.25,308.0,1081629.0,Granules gets USFDA nod for drug,Granules India now has a total of 51 ANDA approvals from the US FDA,neutral,positive,-0.2913564260278334,neutral,-0.4776021080369056,neutral
2022-08-26 18:04:00.000,308.9,312.9,307.25,308.0,1081629.0,Granules India gets USFDA approval for Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets,Granules now have a total of 51 ANDA approvals from USFDA which includes 49 Final approvals and 2 tentative approvals.,positive,neutral,-0.2913564260278334,neutral,-0.4776021080369056,neutral
2022-08-26 19:30:25.000,308.9,312.9,307.25,308.0,1081629.0,Granules India gets FDA approval for new drug to get rid from bothersome mucus,"With this Abbreviated New Drug Application (ANDA) approval for Guaifenesin and Pseudoephedrine Hydrochloride extended-release (ER) tablets, Granules now have a total of 51 ANDA approvals from US FDA.",positive,positive,-0.2913564260278334,neutral,-0.4776021080369056,neutral
2022-08-30 12:14:34.000,304.5,307.9,302.6,306.0,1043816.0,Granules India Gains On US FDA Nod For Imodium-Equivalent Diarrhea Drug,Shares of the company gained as much as 1.95%.,neutral,positive,0.4926108374384236,neutral,0.326797385620915,neutral
2022-08-30 12:16:06.000,304.5,307.9,302.6,306.0,1043816.0,Granules India rises on receiving USFDA nod for diarrhea drug,Granules India rose 1.49% to Rs 306.45 after the company announced that it has received abbreviated new drug application (ANDA) approval for Loperamide Hydrochloride and Simethicone tablets from USFDA.,neutral,positive,0.4926108374384236,neutral,0.326797385620915,neutral
2022-09-16 07:52:29.000,320.0,325.95,313.35,316.9,3448688.0,Derivatives analyst Nandish Shah recommends Bull Spread on Granules India,The analyst from HDFC Securities recommends buying Granules India 320 Call and simultaneously selling 340 Call of the September series.,neutral,positive,-0.9687500000000072,negative,0.3271537622682696,neutral
2022-09-16 21:04:36.000,320.0,325.95,313.35,316.9,3448688.0,Granules India buyback offer opens on Sept 27,Co plans to buyback 62.5 lakh shares at ₹400/share,neutral,neutral,-0.9687500000000072,negative,0.3271537622682696,neutral
2022-09-19 08:57:53.000,320.95,327.0,317.1,322.0,4602304.0,"Stocks that will see action on September 19, 2022","Buzzing stocks: ACC, Ambuja Cement, Adani Power, M&M, Tata Power, TVS Electronics, HDFC Life, Zomato, Granules India, Indus Towers, RattanIndia Enterprises, DLF, Shree Renuka Sugars, Welspun Corp, Ujjivan SFB, SAL Steel",neutral,neutral,0.3271537622682696,neutral,-4.525728456292629,negative
2022-09-21 14:01:51.000,314.0,326.0,307.75,325.35,2705139.0,Granules India Buyback opens on Sep 27: Should you tender the stock?,Single digit buyback returns may soothe tepid stock performance of last two years,neutral,positive,3.61464968152867,positive,-1.2269938650306749,negative
2022-09-30 12:16:04.000,331.95,347.0,325.05,346.6,9313671.0,Alembic Ltd leads gainers in ‘A’ group,"Heritage Foods Ltd, Schneider Electric Infrastructure Ltd, Adani Green Energy Ltd and Granules India Ltd are among the other gainers in the BSE’s ‘A’ group today, 30 September 2022.",positive,neutral,4.413315258322046,positive,0.3448275862068933,neutral
2022-10-03 12:51:18.000,351.0,358.55,347.5,356.5,2737342.0,"Nifty Pharma outshines benchmarks, up 2%; Cipla, Sun Pharma hit 52-wk highs","Shares of Glenmark Pharma, Granules India, Divi’s Laboratories, Torrent Pharma, Lupin and Aurobindo Pharma, surged in the range of 2 per cent to 6 per cent in Monday’s intra-day trade",positive,positive,1.566951566951567,positive,-2.6462395543175488,negative
2022-10-20 14:16:10.000,350.85,352.55,340.8,344.65,1244548.0,Granules Q2 PAT rises 80% YoY; net debt to EBITDA at 0.61x,"Granules India reported 80% jump in net profit to Rs 145 crore on a 30% increase in revenue from operations to Rs 1,151 crore in Q2 FY23 over Q2 FY22.",positive,positive,-1.7671369531138792,negative,-0.8807392434305549,neutral
2022-10-20 15:06:06.000,350.85,352.55,340.8,344.65,1244548.0,Granules India’s Q2 net profit up 80% at ₹145 crore,"The revenue of the Hyderabad-based company grew 30% to ₹1,151 crore",positive,positive,-1.7671369531138792,negative,-0.8807392434305549,neutral
2022-10-20 15:51:15.000,350.85,352.55,340.8,344.65,1244548.0,Paracetamol maker Granules India Q2 net profit jumps 80% to Rs 145 cr,"Pharmaceutical company Granules India Ltd reported an 80% surge in quarterly profit on Thursday, boosted by higher sales of painkiller drug Paracetamol",positive,positive,-1.7671369531138792,negative,-0.8807392434305549,neutral
2022-10-21 12:19:19.000,350.85,352.55,340.8,344.65,1244548.0,Granules India Q2 Results Review - Recovery In Paracetamol Sales To Continue: KRChoksey,"Growth in revenue was driven by higher paracetamol active pharma ingredient sales, increased market share new product launches.",neutral,positive,-1.7671369531138792,negative,-0.8807392434305549,neutral
2022-10-27 06:13:00.000,355.5,370.0,352.8,369.2,3665935.0,Today’s Pick: Granules India (₹354.50): BUY,The short-term outlook is bullish. The stock has been range bound between ₹339 and ₹361 for more tha,neutral,positive,3.853727144866382,positive,-1.4232008592910728,negative
2022-10-27 16:30:36.000,372.4,372.5,362.6,367.1,1997978.0,Buy Granules India; target of Rs 410: ICICI Direct,"ICICI Direct is bullish on Granules India recommended buy rating on the stock with a target price of Rs 410 in its research report dated October 25, 2022.",neutral,positive,-1.4232008592910728,negative,0.9067532819055416,positive
2022-10-28 06:35:59.000,372.4,372.5,362.6,367.1,1997978.0,"Hot Stocks | Container Corp, Bharat Forge, Granules India can give up to 22% return in short term. Here’s why","Bharat Forge, post August 2021, corrected with decreasing volumes. This tells that the stock has weak supply.",positive,negative,-1.4232008592910728,negative,0.9067532819055416,positive
2022-11-01 16:37:01.000,373.0,377.75,368.05,376.5,1777782.0,Hold Granules India; target of Rs 400: Sharekhan,"Sharekhan recommended Hold rating on Granules India with a target price of Rs 400 in its research report dated October 28, 2022.",neutral,positive,0.938337801608579,positive,0.4913678618857962,neutral
2022-12-01 17:01:48.000,341.55,342.8,335.65,339.6,836814.0,Granules India to set up packaging unit in the US with $12.5 m investment,"Krishna Prasad Chigurupati, Founder and Managing Director, says, ‘This will bolster the robustness of Granules’ supply chain’",neutral,positive,-0.5709266578831763,neutral,0.0879249706916797,neutral
2022-12-23 05:00:00.000,326.15,343.15,323.55,329.8,4163284.0,"Stocks To Watch: Reliance Industries, Biocon, IDFC First Bank, Lupin, Yes Bank, NTPC, Granules India",Stocks to watch before going into trade today.,neutral,neutral,1.119116970719005,positive,-0.4832376925400249,neutral
2022-12-26 11:15:15.000,331.1,332.85,322.5,329.5,1707524.0,Buy Granules India; target of Rs 400: Sharekhan,"Sharekhan is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 400 in its research report dated December 23, 2022.",neutral,positive,-0.4832376925400249,neutral,0.1061732140148711,neutral
2022-12-26 17:30:00.000,329.65,332.65,325.75,330.0,695313.0,"NMDC, Granules India, Jyothy Labs, Can Fin Homes & Radico Khaitan: What analysts said on these 5 stocks","NMDC shares are trading at 4 times FY24 EV/Ebitda. With no more capex-intensive programs, the company is likely to generate a strong cash flow, Motilal said, even as the brokerage is factoring a lower iron ore price regime",neutral,positive,0.1061732140148711,neutral,-0.7587253414264037,neutral
2022-12-27 13:10:01.000,329.5,330.95,326.8,327.0,493267.0,"PNB, Granules India among 4 stocks to buy","Sharekhan by BNP Paribas has given buy recommendation for PNB, Hindustan Aeronautics, Granules India and Jyothi Labs. Read on to the target prices for each:",positive,positive,-0.7587253414264037,neutral,-1.8151311775472811,negative
2023-01-02 11:31:10.000,319.35,322.65,313.9,321.0,617096.0,Granules India Ltd down for fifth straight session,"Granules India Ltd is quoting at Rs 316.6, down 0.69% on the day as on 11:09 IST on the NSE. The stock tumbled 5.76% in last one year as compared to a 3.24% rally in NIFTY and a 11.46% fall in the Nifty Metal index.",negative,negative,0.5166744950680999,neutral,1.4906832298136683,positive
2023-01-03 09:31:04.000,322.0,329.7,322.0,326.8,1637141.0,Granules India forges strategic partnership with Greenko ZeroC,To develop and promote carbon free energy and green molecule solutions,positive,neutral,1.4906832298136683,positive,-1.676829268292683,negative
2023-01-03 09:50:40.000,322.0,329.7,322.0,326.8,1637141.0,Granules India gains after collaboration with Greenko ZeroC,Granules India rose 2.61% to Rs 328.70 after the company entered into a strategic partnership with Greenko ZeroC to enable carbon free energy and green molecule solutions.,positive,positive,1.4906832298136683,positive,-1.676829268292683,negative
2023-01-03 17:30:00.000,328.0,328.9,321.55,322.5,453704.0,Granules India shares jump 3% today. Here’s why,"Granules India shares rose 2.8 per cent to hit a high of Rs 329.35 on BSE. With this, the scrip is up 16 per cent in the last six months",positive,positive,-1.676829268292683,negative,0.4162812210915713,neutral
2023-01-03 19:20:21.000,328.0,328.9,321.55,322.5,453704.0,Granules India ties up with Greenko Group for ‘green’ pharma zones,"Pharma Sector : As a part of the partnership, Granules and Greenko ZeroC will develop and promote state-of-the-art Integrated Green Pharmaceutical Zones (GPZ) with first collaboration in Kakinada, Andhra Pradesh",neutral,neutral,-1.676829268292683,negative,0.4162812210915713,neutral
2023-01-24 15:04:07.000,308.9,308.9,288.0,289.45,2427443.0,Granules Q3 PAT rises 23% YoY to Rs 124 cr,"Granules India reported 23.24% jump in net profit to Rs 124.32 crore on a 15% increase in revenue from operations to Rs 1,146.12 crore in Q3 FY23 over Q3 FY22.",positive,positive,-6.296536095823887,negative,-1.4359861591695424,negative
2023-01-24 16:51:41.000,308.9,308.9,288.0,289.45,2427443.0,Paracetamol maker Granules India posts 23% rise in Q3 profit,"Consolidated profit rose to 1.24 billion rupees ($15.22 million) for the three months ended Dec. 31, from 1.01 billion rupees a year earlier.",positive,positive,-6.296536095823887,negative,-1.4359861591695424,negative
2023-01-31 15:45:09.000,296.4,299.4,287.15,292.8,739502.0,Buy Granules India; target of Rs 355: ICICI Direct,"ICICI Direct is bullish on Granules India recommended buy rating on the stock with a target price of Rs 355 in its research report dated January 28, 2023.",neutral,positive,-1.2145748987854137,negative,-0.7692307692307693,neutral
2023-02-27 07:29:44.000,285.0,287.8,280.6,280.95,433023.0,"Stocks to watch: SpiceJet, IOC, Granules India, Phoenix Mills, ABB India","Stocks to watch: From SpiceJet to Indian Oil Corporation, here are top stocks likely to be in action in Monday’s trading session",neutral,neutral,-1.4210526315789511,negative,-0.6917346576800244,neutral
2023-02-27 07:48:39.000,285.0,287.8,280.6,280.95,433023.0,"Stocks to Watch: IndiGo, SpiceJet, IOC, Paytm, Vodafone Idea, Granules India, and Others","Stocks to watch: Shares of firms like IndiGo, SpiceJet, IOC, Paytm, Vodafone Idea, Granules India, and others will be in focus in Monday’s trade.",neutral,neutral,-1.4210526315789511,negative,-0.6917346576800244,neutral
2023-02-27 09:04:09.000,285.0,287.8,280.6,280.95,433023.0,"Granules India, Power Grid Corp, Marico, SpiceJet in spotlight","Granules India: The US Food & Drug Administration (US FDA) has approved the drug maker’s Abbreviated New Drug Application (ANDA) for Losartan Potassium Tablets USP, 25 mg, 50 mg, and 100 mg. It is bioequivalent to the reference listed drug product",neutral,neutral,-1.4210526315789511,negative,-0.6917346576800244,neutral
2023-02-27 09:31:23.000,285.0,287.8,280.6,280.95,433023.0,Granules India receives USFDA approval for Losartan Potassium Tablets,"It is bioequivalent to the reference listed drug product (RLD), Cozaar Tablets of Organon LLC.",positive,neutral,-1.4210526315789511,negative,-0.6917346576800244,neutral
2023-02-27 09:50:17.000,285.0,287.8,280.6,280.95,433023.0,Granules India secures FDA nod to hypertension drug but share price falls,"The company now has a total of 54 ANDA approvals from USFDA, including 52 final approvals and 2 tentative approvals.",negative,positive,-1.4210526315789511,negative,-0.6917346576800244,neutral
2023-02-27 09:50:26.000,285.0,287.8,280.6,280.95,433023.0,Granules India gets USFDA nod for Losartan Potassium tablets,The pharmaceutical company announced that it has received approval from US Food and Drug Administration (USFDA) for its abbreviated new drug and application (ANDA) for Losartan Potassium tablets.,neutral,positive,-1.4210526315789511,negative,-0.6917346576800244,neutral
2023-02-27 11:51:55.000,285.0,287.8,280.6,280.95,433023.0,Granules gets USFDA nod to market generic medication to treat high blood pressure,"The company has received approval from the US Food & Drug Administration (USFDA) to market Losartan Potassium tablets in strengths of 25 mg, 50 mg, and 100 mg, Granules India said in a regulatory filing.",positive,positive,-1.4210526315789511,negative,-0.6917346576800244,neutral
2023-02-27 12:00:46.000,281.9,285.1,279.2,279.95,434045.0,Granules gets USFDA nod to market generic medicine for high blood pressure,Drug firm Granules India on Monday said it has received approval from the US health regulator to market a generic product to treat high blood pressure.,neutral,positive,-0.6917346576800244,neutral,1.2841091492776764,positive
2023-02-27 16:13:01.000,281.9,285.1,279.2,279.95,434045.0,Granules India gets USFDA nod for hypertension drug,The drug is indicated for treatment of hypertension in adults and paediatric patients 6 years of age and older,neutral,neutral,-0.6917346576800244,neutral,1.2841091492776764,positive
2023-03-21 14:41:10.000,289.45,289.95,285.3,288.4,195112.0,Granules India shares rise as arm concludes US FDA audit,Granules Consumer Health’s packaging unit in Manassas was inspected by the US FDA from March 15-20.,positive,neutral,-0.3627569528416001,neutral,-1.6972878390201305,negative
2023-03-21 15:16:13.000,289.45,289.95,285.3,288.4,195112.0,Granules India rises after arm clears USFDA audit,"Granules India gained 2.24% to Rs 288.15 after the drug maker said that its step-down subsidiary, Granules Consumer Health Inc has completed the United States Food and Drug Administration (USFDA) audit with zero observations.",neutral,positive,-0.3627569528416001,neutral,-1.6972878390201305,negative
2023-03-21 20:09:06.000,289.45,289.95,285.3,288.4,195112.0,Granules arm completes U.S. FDA audit,Drugmaker Granules India’s step-down subsidiary Granules Consumer Health Inc. (GCH) has completed an audit by the U.S. Food and Drug Administration (U.S. FDA) with zero observations.,neutral,neutral,-0.3627569528416001,neutral,-1.6972878390201305,negative
2023-03-29 09:58:45.000,268.5,275.0,267.75,274.0,1065781.0,Granules India gets USFDA nod for Gabapentin Tablets; share price falls,Granules now have a total of 55 ANDA approvals from USFDA.,negative,neutral,2.0484171322160147,positive,5.781818181818173,positive
2023-03-29 17:20:00.000,268.5,275.0,267.75,274.0,1065781.0,Granules India receives USFDA approval for generic gabapentin tablets,"These tablets are bioequivalent to the reference listed drug product, Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty LLC.",positive,neutral,2.0484171322160147,positive,5.781818181818173,positive
2023-03-29 18:55:00.000,268.5,275.0,267.75,274.0,1065781.0,Granules India gets USFDA nod for gabapentin tablets,Granules India has received USFDA approval for its abbreviated new drug application (ANDA) for gabapentin tablets,neutral,positive,2.0484171322160147,positive,5.781818181818173,positive
2023-05-16 08:43:46.000,294.0,302.45,284.0,284.85,3733411.0,"Stocks to watch on May 16, 2023","Buzzing stocks of IOC, Bharti Airtel, LIC Housing, Bank of Baroda, Jindal Steel & Power, Chemplast Sanmar, Eiko Life, CreditAccess, Granules India, Paris Defence, HDFC, SAT Industries, Jupiter Wagons, Rajoo Engineers, HDFC, Vedanta",neutral,neutral,-3.112244897959176,negative,-0.7115584866365884,neutral
2023-05-16 17:23:16.000,288.1,298.2,280.1,286.05,4541140.0,"Granules India Consolidated March 2023 Net Sales at Rs 1,195.50 crore, up 16.07% Y-o-Y",,positive,neutral,-0.7115584866365884,neutral,-3.166318719554616,negative
2023-05-16 17:54:06.000,288.1,298.2,280.1,286.05,4541140.0,"Granules India Standalone March 2023 Net Sales at Rs 1,013.88 crore, up 11.07% Y-o-Y",,positive,neutral,-0.7115584866365884,neutral,-3.166318719554616,negative
2023-05-16 18:41:15.000,288.1,298.2,280.1,286.05,4541140.0,Granules profit up 7.8% to Rs 120 crore boosted by drug ingredient business,"Granules India reported a 7.8% rise in fourth-quarter profit, spurred by strong growth in its business of making active pharmaceutical ingredient (API) for drugs",positive,positive,-0.7115584866365884,neutral,-3.166318719554616,negative
2023-05-16 20:29:05.000,288.1,298.2,280.1,286.05,4541140.0,Granules India’s Q4 net up 8% at ₹120 crore,"The revenue increased 16 per cent at ₹1,195 crore as against ₹1,030 crore in the year ago period",positive,positive,-0.7115584866365884,neutral,-3.166318719554616,negative
2023-05-17 09:16:13.000,288.1,298.2,280.1,286.05,4541140.0,"Granules India Q4 Results Review - Finished Dosage, API Propel Earnings For The Quarter: Motilal Oswal",Work-in-progress for capex of key intermediates/green energy.,neutral,neutral,-0.7115584866365884,neutral,-3.166318719554616,negative
2023-05-18 23:19:29.000,280.0,280.0,274.15,276.3,1268082.0,Buy Granules India; target of Rs 350: Sharekhan,"Sharekhan is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 350 in its research report dated May 17, 2023.",neutral,positive,-1.3214285714285674,negative,1.245421245421237,positive
2023-05-25 14:50:00.000,273.05,277.85,272.35,277.3,805660.0,Granules India reports ‘information security incident’; isolates impacted IT assets,"The appropriate containment and remediation actions are being taken in a controlled manner to address the incident, it added. In March, Sun Pharma also reported an information security incident at the company.",neutral,neutral,1.5564914850759934,positive,1.3489208633093526,positive
2023-06-13 15:35:54.000,286.8,289.0,285.55,287.1,1238528.0,Buy Granules India; target of Rs 342: Geojit,"Geojit is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 342 in its research report dated June 13, 2023.",neutral,positive,0.104602510460255,neutral,-0.5026867741376282,neutral
2023-06-13 21:27:51.000,286.8,289.0,285.55,287.1,1238528.0,U. S. FDA nod for Granules’ copy of hypertension drug,"The U.S. Food and Drug Administration (U.S. FDA) has approved Granules India’s abbreviated new drug application for hypertension drug Metoprolol Succinate Extended-Release Tablets USP, 25 mg, 50 mg, 100 mg and 200 mg.",neutral,positive,0.104602510460255,neutral,-0.5026867741376282,neutral
2023-06-14 14:59:05.000,288.45,289.0,285.0,287.0,1157242.0,Granules copy of seizure drug gets U.S. FDA nod,"The U.S Food and Drug Administration (U.S. FDA) has approved drugmaker Granules India’s abbreviated new drug application for Levetiracetam Tablets USP, 250 mg, 500 mg, 750 mg, and 1,000 mg.",neutral,positive,-0.5026867741376282,neutral,1.2150668286755772,positive
2023-06-19 13:36:16.000,295.2,295.2,291.0,293.5,1034971.0,Buy Granules India; target of Rs 360: ICICI Direct,"ICICI Direct is bullish on Granules India recommended buy rating on the stock with a target price of Rs 360 in its research report dated June 19, 2023.",neutral,positive,-0.5758807588075843,neutral,-1.0034013605442138,negative
2023-06-28 20:43:14.000,298.45,302.6,295.0,300.6,2240921.0,Drug Abuse: Granules India joins hands with CBN to create awareness,"Granules India partners with the Central Bureau of Narcotics to raise awareness about drug abuse on the International Day against Drug Abuse and Illicit Trafficking. Through engaging activities, Granules educates the public about the dangers of illicit drugs, aiming to foster responsibility and awar…",neutral,neutral,0.7203886748199143,neutral,-0.3687562856185125,neutral
2023-06-29 13:22:00.000,298.3,299.8,293.55,297.2,2433951.0,Granules India flags significant loss of revenue as it continues to recover from cyber attack,"Pharmaceutical company Granules India has reported a significant loss of revenue and profitability after a cyber security attack late last month. The attack led to major disruptions in the company’s IT systems, as well as delays in meeting regulatory requirements and quality standards. The company h…",negative,negative,-0.3687562856185125,neutral,-1.0596026490066186,negative
2023-06-29 13:51:45.000,298.3,299.8,293.55,297.2,2433951.0,"Cyber attack has caused significant loss to revenue, profitability: Granules India","Due to significant changes in its IT systems, the IT security incident caused a major disruption in its business operations, the Paracetamol maker said in an exchange filing.",negative,negative,-0.3687562856185125,neutral,-1.0596026490066186,negative
2023-06-29 14:02:33.000,298.3,299.8,293.55,297.2,2433951.0,Paracetamol maker Granules India flags operations hit from cyber attack,"Due to significant changes in its IT systems, the IT security incident caused a major disruption in its business operations, the Paracetamol maker said in an exchange filing",negative,negative,-0.3687562856185125,neutral,-1.0596026490066186,negative
2023-06-29 20:43:45.000,298.3,299.8,293.55,297.2,2433951.0,"Granules stares at major loss of revenue, profitability after cyber attack",Drugmaker Granules India on Thursday warned of a significant loss of revenue and profitability from the IT security incident that it came under last month.,negative,negative,-0.3687562856185125,neutral,-1.0596026490066186,negative
2023-06-30 11:35:49.000,298.3,299.8,293.55,297.2,2433951.0,Granules India falls after cyberattack erodes topline,"On June 29, Granules India Ltd. reported a significant loss of revenue and profitability caused due to a cyber security breach attack incurred by the company last month.",neutral,negative,-0.3687562856185125,neutral,-1.0596026490066186,negative
2023-06-30 21:19:49.000,298.3,299.8,293.55,297.2,2433951.0,Granules India sees ‘major effect’ of IT security incident on operations,Enhanced security measures are being implemented to handle the ongoing incident and reduce the likelihood of a similar occurrence in the future.,neutral,positive,-0.3687562856185125,neutral,-1.0596026490066186,negative
2023-06-30 22:47:09.000,298.3,299.8,293.55,297.2,2433951.0,U.S. FDA completes inspection of Granules unit in Vizag,"Drugmaker Granules India’s active pharmaceutical ingredients (API) manufacturing unit in Visakhapatnam, Andhra Pradesh, has completed a U.S. Food and Drug Administration (U.S. FDA) inspection.",neutral,positive,-0.3687562856185125,neutral,-1.0596026490066186,negative
2023-07-03 09:19:06.000,302.0,304.6,297.55,298.8,2285841.0,"Stocks that will see action today: July 3, 2023","Buzzing stocks: Automobile stocks, Reliance Industries, Adani Transmission, Zomato, Granules India, Kansai Nerolac, Factor Alloyds, Siemens, Dynamic Tech, GTPL Hathway, Shiva Cement",neutral,neutral,-1.0596026490066186,negative,-1.2531328320802004,negative
2023-07-07 08:27:41.000,301.0,315.4,300.0,311.8,11435944.0,Granules India - Improved Business Trajectory Fueled By U.S. ANDA Approvals: Motilal Oswal,"We expect a 17% earnings CAGR, a 12% sales CAGR in Intermediates/API segment, and a 10% CAGR in the formulation segment.",neutral,positive,3.588039867109638,positive,-1.4299332697807436,negative
2023-07-13 19:51:07.000,305.3,310.45,302.35,308.6,1768819.0,Granules facility in Hyderabad gets EIR from U.S. FDA,"Granules India’s Gagillapur facility receives EIR after PAI in Jan 2023 , which resulted in three observations",neutral,neutral,1.080904028824111,positive,-0.3685897435897363,neutral
2023-07-14 09:53:45.000,305.3,310.45,302.35,308.6,1768819.0,Granules India foreign subsidiary gets USFDA approval; stock price gains,This product will be launched through Granules Consumer Health (GCH) division.,positive,neutral,1.080904028824111,positive,-0.3685897435897363,neutral
2023-08-04 10:07:41.000,320.0,325.4,317.3,318.2,1933530.0,Granules Pharma clears US FDA inspection with zero observation; shares gain,This is Granules India’s fourth FDA audit since March with zero observations.,positive,neutral,-0.5625000000000036,neutral,0.0312109862671731,neutral
2023-08-04 22:20:38.000,320.0,325.4,317.3,318.2,1933530.0,Granules arm completes U.S. FDA’s PADE inspection,This is Granules India’s fourth FDA audit since March with zero observations,neutral,neutral,-0.5625000000000036,neutral,0.0312109862671731,neutral
2023-08-09 21:14:06.000,306.25,315.0,301.0,301.6,7110976.0,"IT security incident dents Granules Q1 net, revenue",Drugmaker Granules India reported consolidated net profit declined more than 62% year-on-year to nearly ₹48 crore during the June quarter on a 3% drop in revenue from operations to ₹985.516 crore.,neutral,negative,-1.5183673469387682,negative,-1.3245033112582782,negative
2023-08-10 10:49:32.000,306.25,315.0,301.0,301.6,7110976.0,Granules India Q1 Results Review - IT Issue Adversely Impacted Earnings: Motilal Oswal,"On track to implement green project, backward integration.",neutral,neutral,-1.5183673469387682,negative,-1.3245033112582782,negative
2023-08-10 13:16:02.000,302.0,303.15,297.0,298.0,1703982.0,Granules India down over 4% as Q1 profit declines,Granules India’s net profit tanked 62.4 percent YoY to Rs 47.9 crore.,negative,positive,-1.3245033112582782,negative,-2.097315436241611,negative
2023-08-14 14:27:00.000,298.0,298.4,287.7,291.75,2163421.0,Buy Granules India; target of Rs 370: Motilal Oswal,"Motilal Oswal is bullish on Granules India recommended buy rating on the stock with a target price of Rs 370 in its research report dated August 09, 2023.",neutral,positive,-2.097315436241611,negative,1.0309278350515465,positive
2023-08-21 21:24:49.000,298.5,299.15,294.55,294.95,1146860.0,Trade setup for Tuesday: Top 15 things to know before the opening bell,"Based on the OI percentage, 81 stocks were on the short-covering list. These included ITC, Granules India, Ipca Laboratories, Lupin, and Atul. A decrease in OI along with a price increase is an indication of short-covering.",neutral,neutral,-1.1892797319933035,negative,-0.3885791518837564,neutral
2023-08-25 05:00:00.000,296.3,300.8,292.65,293.5,1637944.0,"Stocks To Watch: Reliance Industries, Shoppers Stop, Bharti Airtel, Granules India, Bharat Electronics",Here are the stocks to watch before going into trade today.,neutral,neutral,-0.9449881876476582,negative,1.0506693780715015,positive
2023-08-25 07:38:04.000,296.3,300.8,292.65,293.5,1637944.0,"Stocks that will see action today: August 25, 2023","Block deals galore: Antfin to sell 3.6% stake in Paytm, Intl. Conveyors, Elpro Intl. acquire BSE shares, Reliance & Oberoi to manage 3 properties, Granules India gets ANVISA approval, Vedanta wins arbitration award, KPI Green Energy gets GEDA approval, TT signs MOU with U.P. Govt., Omega Seiki ties …",neutral,neutral,-0.9449881876476582,negative,1.0506693780715015,positive
2023-08-25 09:57:13.000,296.3,300.8,292.65,293.5,1637944.0,"Granules India gains on nod from Japanese, Brazilian drug regulators",The pharmaceutical raw-materials manufacturer has received approvals from the foreign drug regulators for its Jeedimetla and Bonthapally manufacturing facilities in Telangana,positive,positive,-0.9449881876476582,negative,1.0506693780715015,positive
